unlik
area
diagnost
laboratori
clinic
microbiolog
scienc
interpret
judgment
becom
complex
less
even
advent
laboratori
autom
integr
genom
proteom
microbiolog
interpret
result
still
depend
qualiti
specimen
receiv
analysi
prokaryot
microorgan
genet
less
complex
multicellular
eukaryot
uniqu
suit
adapt
environ
antibiot
host
respons
appli
pressur
encourag
surviv
laboratori
instrument
may
may
detect
mutat
specialist
microbiolog
need
facilit
microbiolog
laboratori
result
interpret
clearli
microb
grow
multipli
die
quickli
event
occur
specimen
collect
transport
storag
result
analysi
compromis
interpret
could
mislead
therefor
attent
preanalyt
specimen
manag
microbiolog
critic
accuraci
physician
need
confid
result
provid
microbiolog
laboratori
accur
signific
clinic
relev
anyth
less
commun
standard
care
order
provid
level
qualiti
howev
laboratori
requir
microbiolog
specimen
properli
select
collect
transport
optim
analysi
interpret
result
interpret
microbiolog
depend
entir
qualiti
specimen
submit
analysi
specimen
manag
left
chanc
collect
specimen
microbiolog
analysi
must
awar
physician
need
well
laboratori
need
includ
ensur
specimen
arriv
laboratori
analysi
quickli
possibl
collect
introductiont
elementari
level
physician
need
answer
basic
question
laboratori
patient
ill
caus
microb
suscept
profil
organ
therapi
target
meet
need
laboratori
requir
differ
inform
microbiolog
laboratori
need
specimen
appropri
select
collect
transport
laboratori
analysi
caught
middl
physician
laboratori
select
collect
specimen
may
know
understand
physician
laboratori
need
work
enhanc
qualiti
specimen
everyon
job
commun
physician
nurs
laboratori
staff
encourag
open
punit
motiv
consequ
diagnosi
infecti
diseas
best
achiev
appli
indepth
knowledg
medic
laboratori
scienc
along
principl
epidemiolog
pharmacokinet
antibiot
integr
strateg
view
hostparasit
interact
clearli
best
outcom
patient
result
strong
partnership
clinician
laboratorian
specialist
document
illustr
partnership
emphas
import
appropri
specimen
manag
clinic
relev
result
one
valuabl
laboratori
partner
infecti
diseas
diagnosi
certifi
microbiolog
specialist
particularli
specialist
certifi
diplom
american
board
medic
microbiolog
abmm
american
board
patholog
abp
american
board
medic
laboratori
immunolog
abmli
equival
certifi
organ
clinician
recommend
medic
institut
provid
kind
leadership
microbiolog
laboratori
provid
formal
access
level
laboratori
expertis
consult
microbiolog
specimen
select
collect
respons
medic
staff
usual
laboratori
although
certifi
specialist
may
call
upon
consult
assist
impact
proper
specimen
manag
patient
care
enorm
key
accur
laboratori
diagnosi
confirm
directli
affect
patient
care
patient
outcom
influenc
therapeut
decis
impact
hospit
infect
control
impact
patient
length
stay
hospit
cost
laboratori
cost
influenc
laboratori
effici
clinician
consult
laboratori
ensur
select
collect
transport
storag
patient
specimen
perform
properli
throughout
text
caveat
relev
specif
specimen
diagnost
protocol
infecti
diseas
diagnosi
howev
strateg
tenet
specimen
manag
test
microbiolog
stand
commun
standard
care
set
microbiolog
apart
laboratori
depart
chemistri
hematolog
ten
point
import
microbiolog
laboratori
polici
manual
avail
time
medic
staff
review
consult
would
particularli
help
encourag
nurs
staff
review
specimen
collect
manag
portion
manual
facilit
collabor
laboratori
microbiolog
expertis
specimen
collect
personnel
may
know
littl
microbiolog
laboratori
need
order
establish
confirm
diagnosi
welcom
engag
microbiolog
laboratori
integr
part
healthcar
team
encourag
hospit
laboratori
facil
boardcertifi
laboratori
specialist
hand
avail
optim
infecti
diseas
laboratori
diagnosi
full
text
document
avail
onlin
organ
bodi
system
although
mani
organ
capabl
caus
diseas
one
bodi
system
may
redund
mention
organ
propens
infect
multipl
site
one
uniqu
featur
document
abil
assist
clinician
specif
suspicion
regard
possibl
etiolog
agent
caus
specif
type
diseas
anoth
uniqu
featur
section
target
recommend
precaut
regard
select
collect
specimen
analysi
diseas
process
within
section
tabl
describ
specimen
need
regard
varieti
etiolog
agent
one
may
suspect
caus
ill
test
method
tabl
list
prioriti
order
accord
recommend
author
review
room
temperatur
rt
specifi
certain
time
period
hour
expect
sampl
refriger
time
unless
specifi
otherwis
section
almost
specimen
viru
detect
transport
wet
ice
frozen
test
delay
hour
although
specimen
viral
transport
media
may
transport
room
temperatur
rapid
hour
deliveri
laboratori
assur
document
endors
infecti
diseas
societi
america
idsa
american
societi
microbiolog
asm
futur
modif
expect
diagnost
microbiolog
dynam
rapidli
chang
disciplin
diagnosi
bloodstream
infect
bsi
one
critic
function
clinic
microbiolog
laboratori
great
major
etiolog
agent
bsi
convent
blood
cultur
method
provid
result
within
hour
incub
day
seldom
requir
modern
autom
continuousmonitor
blood
cultur
system
media
use
includ
recoveri
histor
fastidi
organ
hacek
haemophilu
aggregatibact
cardiobacterium
eikenella
kingella
bacteria
brucella
spp
microorgan
mycobacteria
dimorph
fungi
requir
longer
incub
period
other
may
requir
special
cultur
media
nonculturebas
method
although
filamenti
fungi
often
requir
special
broth
media
lysiscentrifug
vial
detect
candida
spp
tend
grow
well
standard
blood
cultur
broth
unless
patient
antifung
therapi
unfortun
blood
cultur
patient
suspect
candidemia
yield
posit
result
almost
half
patient
tabl
provid
summari
diagnost
method
bsi
etiolog
agent
infect
endocard
convent
blood
cultur
method
suffic
howev
less
common
etiolog
agent
detect
current
blood
cultur
method
common
etiolog
agent
cultureneg
endocard
bartonella
spp
coxiella
burnetii
often
detect
convent
serolog
test
howev
molecular
amplif
method
may
need
detect
organ
well
other
eg
tropheryma
whipplei
rare
instanc
cultureneg
endocard
polymeras
chain
reaction
pcr
dna
sequenc
valv
tissu
may
help
determin
etiolog
agent
volum
blood
obtain
blood
cultur
request
also
known
blood
cultur
set
consist
bottl
procur
singl
venipunctur
one
cathet
draw
import
variabl
recov
bacteria
fungi
patient
bloodstream
infect
adult
ml
blood
per
cultur
set
depend
manufactur
instrument
recommend
may
requir
bottl
depend
system
children
age
weightappropri
volum
blood
cultur
see
tabl
recommend
volum
second
import
determin
number
blood
cultur
set
perform
given
septic
episod
gener
adult
suspicion
bsi
blood
cultur
set
obtain
evalu
septic
episod
time
blood
cultur
order
dictat
patient
acuiti
urgent
situat
blood
cultur
set
obtain
sequenti
short
time
interv
empir
therapi
initi
less
urgent
situat
obtain
blood
cultur
set
may
space
sever
hour
contamin
blood
cultur
bottl
common
costli
healthcar
system
frequent
confus
clinician
minim
risk
contamin
blood
cultur
commens
skin
flora
meticul
care
taken
skin
prepar
prior
venipunctur
consensu
guidelin
expert
panel
recommend
peripher
venipunctur
prefer
techniqu
obtain
blood
cultur
base
data
show
blood
obtain
fashion
less
like
contamin
blood
obtain
intravascular
cathet
devic
sever
studi
document
iodin
tinctur
chlorin
peroxid
chlorhexidin
glucon
chg
superior
povidoneiodin
prepar
skin
disinfect
blood
cultur
data
summar
ref
iodin
tinctur
chg
requir
second
exert
antisept
effect
compar
minut
povidoneiodin
prepar
chg
recommend
use
infant
less
month
age
blood
cultur
contamin
skin
flora
collect
common
contamin
rate
exceed
laboratori
polici
procedur
abbrevi
workup
report
common
blood
cultur
contamin
eg
coagulaseneg
staphylococci
viridan
group
streptococci
diphtheroid
bacillu
speci
b
anthraci
procedur
may
includ
abbrevi
identif
organ
absenc
suscept
test
comment
instruct
clinician
contact
laboratori
cultur
result
thought
clinic
signific
requir
addit
workup
suscept
result
physician
expect
call
notifi
laboratori
everi
time
blood
cultur
becom
posit
specimen
often
repres
lifethreaten
infect
physician
wish
notifi
specif
time
arrang
must
made
physician
deleg
healthcar
profession
receiv
call
relay
report
diagnosi
catheterassoci
bsi
often
one
exclus
microbiolog
gold
standard
diagnosi
exist
although
number
differ
microbiolog
method
describ
avail
data
allow
firm
conclus
made
rel
merit
variou
diagnost
techniqu
fundament
diagnosi
catheterassoci
bsi
document
bacteremia
clinic
signific
posit
cultur
indwel
cathet
segment
tip
absenc
posit
blood
cultur
unknown
next
essenti
diagnost
compon
demonstr
infect
caus
cathet
usual
requir
exclus
potenti
primari
foci
bsi
numer
diagnost
techniqu
cathet
cultur
describ
may
provid
adjunct
evid
catheterassoci
bsi
howev
potenti
pitfal
make
interpret
result
problemat
routin
cultur
intraven
iv
cathet
tip
time
cathet
remov
clinic
valu
done
although
perform
laboratori
method
describ
includ
follow
infect
mycot
aneurysm
infect
vascular
graft
may
result
posit
blood
cultur
definit
diagnosi
requir
microscop
visual
andor
cultur
recoveri
etiolog
agent
repres
biopsi
graft
materi
tabl
numer
virus
bacteria
rickettsia
fungi
parasit
implic
etiolog
agent
pericard
myocard
mani
patient
pericard
overwhelm
major
patient
myocard
etiolog
diagnosi
never
made
patient
treat
empir
select
instanc
import
clinic
defin
specif
caus
infect
microbiolog
diagnosi
pursu
aggress
unfortun
howev
avail
diagnost
resourc
quit
limit
firm
diagnost
guidelin
given
common
clinic
import
pathogen
list
tabl
microbiolog
diagnosi
less
common
etiolog
agent
requir
especi
special
techniqu
method
necessari
consult
laboratori
director
undertaken
consider
overlap
pericard
myocard
respect
etiolog
agent
diseas
manifest
common
etiolog
agent
acut
mening
enterovirus
primarili
echovirus
coxsackievirus
bacteria
streptococcu
pneumonia
neisseria
meningitidi
tabl
patient
age
factor
ie
immun
statu
post
neurosurgeri
trauma
associ
specif
bacteri
pathogen
molecular
test
replac
viral
cultur
diagnosi
enterovir
mening
routin
avail
detect
bacteria
csf
sensit
gram
stain
diagnosi
bacteri
mening
patient
receiv
antimicrobi
therapi
patient
receiv
treatment
bacteri
antigen
test
csf
recommend
may
valu
patient
receiv
therapi
prior
specimen
collect
neg
gram
stain
neg
cultur
result
patient
suspect
bacteri
mening
least
blood
cultur
perform
therapi
delay
organ
expect
caus
chronic
mening
symptom
week
includ
mycobacterium
tuberculosi
fungi
spirochet
tabl
sensit
nucleic
acid
amplif
test
naat
tuberculosi
nonrespiratori
specimen
may
poor
cultur
also
request
report
sensit
cultur
diagnos
tubercul
mening
highest
yield
acid
fast
bacillu
afb
smear
afb
cultur
occur
larg
volum
ml
csf
use
perform
test
cryptococc
antigen
test
replac
india
ink
stain
rapid
diagnosi
mening
caus
c
neoforman
c
gattii
readili
avail
laboratori
test
sensit
perform
csf
rather
serum
sensit
specif
cryptococc
antigen
test
fals
neg
fals
posit
result
may
occur
exampl
patient
hivaid
complement
fixat
test
perform
csf
recommend
diagnosi
coccidioid
mening
sinc
direct
fungal
smear
cultur
often
neg
detect
coccidioid
antibodi
csf
immunodiffus
lower
specif
complement
fixat
enceph
infect
brain
parenchyma
caus
abnorm
cerebr
function
alter
mental
statu
behavior
speech
disturb
sensori
motor
deficit
despit
advanc
molecular
technolog
diagnosi
cn
infect
etiolog
agent
enceph
often
identifi
california
enceph
project
identifi
definit
probabl
etiolog
agent
immunocompet
patient
enrol
viral
bacteri
prion
parasit
fungal
possibl
caus
identifi
addit
patient
immun
statu
travel
exposur
histori
insect
anim
water
sexual
guid
test
idsa
practic
guidelin
provid
detail
list
risk
factor
associ
specif
etiolog
agent
although
diagnosi
specif
viral
caus
usual
base
test
perform
csf
test
specimen
collect
site
may
help
viru
commonli
identifi
caus
enceph
herp
simplex
viru
hsv
sensit
specif
naat
hsv
enceph
hsv
cultur
csf
case
sensit
naat
perform
csf
enteroviru
enceph
sensit
cultur
recoveri
throat
stool
circumstanti
etiolog
evid
perform
characterist
molecular
test
caus
viral
enceph
well
establish
serolog
repeat
molecular
test
may
requir
tabl
focal
parenchym
brain
infect
start
cerebr
progress
necrosi
surround
fibrou
capsul
broad
categori
pathogenesi
contigu
spread
otiti
media
sinus
mastoid
dental
infect
trauma
neurosurg
complic
hematogen
spread
distant
site
infect
skin
pulmonari
pelvic
intraabdomin
esophag
endocard
brain
abscess
immunocompet
host
usual
caus
bacteria
tabl
wider
array
organ
encount
immunocompromis
individu
shunt
place
divert
cerebrospin
fluid
treatment
hydrocephalu
proxim
portion
place
cerebr
ventricl
intracrani
cyst
subarachnoid
space
lumbar
region
distal
portion
may
intern
periton
vascular
pleural
space
extern
total
shunt
becom
infect
tabl
potenti
rout
shunt
infect
includ
contamin
time
placement
contamin
distal
portion
retrograd
breakdown
skin
shunt
hematogen
seed
blood
cultur
also
collect
shunt
termin
vascular
space
ventriculoatri
shunt
cn
shunt
infect
caus
bacteria
fungi
like
caus
shunt
infect
immunocompromis
patient
receiv
total
parenter
nutrit
steroid
broadspectrum
antibiot
cranial
subdur
empyema
cranial
epidur
abscess
neurosurg
emerg
usual
caus
bacteria
streptococci
staphylococci
aerob
gramneg
bacilli
anaerob
often
polymicrobi
tabl
mycobacteria
fungi
rare
caus
predispos
condit
includ
sinus
otiti
media
mastoid
neurosurgeri
head
trauma
subdur
hematoma
mening
infant
pathogenesi
spinal
epidur
abscess
includ
hematogen
spread
skin
urinari
tract
mouth
mastoid
lung
infect
direct
extens
vertebr
osteomyel
disciti
trauma
postprocedur
complic
surgeri
biopsi
lumbar
punctur
anesthesia
spinal
epidur
abscess
usual
caus
staphylococci
streptococci
aerob
gramneg
bacilli
anaerob
nocardia
spp
mycobacteria
fungi
may
also
caus
spinal
epidur
abscess
spinal
subdur
empyema
similar
spinal
epidur
abscess
clinic
present
caus
organ
magnet
reson
imag
mri
optim
diagnost
procedur
suppur
intracrani
thrombophleb
etiolog
agent
may
recov
cerebrospin
fluid
blood
cultur
caus
organ
similar
cranial
epidur
abscess
cranial
subdur
empyema
empir
antimicrobi
therapi
usual
base
predispos
clinic
condit
ocular
infect
may
involv
one
eye
etiolog
may
differ
clinician
must
clearli
mark
specimen
eye
sampl
especi
patient
bilater
diseas
collect
specimen
anatom
structur
surround
eye
typic
perform
use
swab
tabl
commonli
collect
specimen
conjunctiva
cultur
aerob
bacteria
detect
chlamydia
virus
either
cultur
nucleic
acid
amplif
test
naat
commonli
perform
direct
microscop
examin
may
use
preliminari
diagnosi
conjunct
obtain
dual
swab
one
cultur
one
smear
prepar
recommend
smear
may
made
gram
stain
calcofluor
stain
fungi
acanthamoeba
direct
fluoresc
antibodi
dfa
chlamydia
trachomati
appropri
transport
media
provid
laboratori
avail
collect
site
specimen
submit
chlamydia
andor
viral
cultur
naat
specimen
viral
cultur
submit
ice
especi
specimen
transport
prolong
specimen
obtain
either
surfac
globe
eye
almost
alway
collect
ophthalmologist
specimen
type
includ
swab
ulcer
corneal
scrape
biopsi
anterior
chamber
vitreou
aspir
volum
specimen
alway
limit
specimen
limit
make
necessari
laboratori
priorit
procedur
depend
organ
sought
alway
done
discuss
ophthalmologist
collect
specimen
infecti
diseas
consult
appropri
particularli
import
major
pathogen
parasit
bacteria
mycobacteria
caus
ocular
infect
epidemiolog
clinic
present
use
narrow
organ
sought
laboratori
test
request
limit
specimen
size
seen
scrape
biopsi
laboratori
ophthalmologist
may
agre
inocul
specimen
onto
media
prepar
smear
bedsid
case
laboratori
suppli
necessari
media
slide
ophthalmologist
suppli
store
clinic
oper
suit
readi
access
surgeon
laboratori
respons
assur
materi
outdat
aspir
anterior
chamber
vitreou
optim
specimen
detect
anaerob
bacteria
viral
agent
submit
syring
needl
remov
syring
place
leakproof
outer
contain
transport
inject
fluid
small
steril
vial
provid
laboratori
prefer
principl
specimen
collect
transport
describ
conjunctiv
specimen
appli
specimen
well
orbit
cellul
almost
alway
complic
sinus
organ
associ
includ
streptococcu
pneumonia
nontyp
haemophilu
influenza
streptococcu
pyogen
moraxella
spp
anaerob
bacteria
aspergillu
spp
zygomycet
periorbit
cellul
usual
aris
result
either
local
trauma
bacteremia
often
caus
staphylococcu
aureu
pyogen
pneumonia
diagnosi
infect
either
base
posit
blood
cultur
case
orbit
cellul
cultur
drainag
materi
aspir
subperiost
region
sinus
blephar
canalicul
dacryocyst
superfici
infect
gener
selflimit
organ
associ
infect
predominantli
gramposit
bacteria
although
variou
gramneg
bacteria
anaerob
fungi
recov
limit
mani
studi
infect
microbiolog
data
control
popul
frequent
lack
organ
commonli
recov
part
indigen
skin
microflora
coagulas
neg
staphylococci
diphtheroid
attribut
pathogen
role
organ
condit
difficult
cultur
site
rare
submit
diagnost
workup
cultur
canalicul
consid
concret
recov
canalicular
compress
canaliculotomi
recommend
strategi
diagnosi
superfici
infect
similar
conjunct
case
conjunct
caus
bacteria
virus
typic
associ
upper
respiratori
tract
infect
distinct
clinic
present
bacteri
viral
conjunct
coupl
selflimit
natur
infect
determin
etiolog
infrequ
attempt
test
request
diagnosi
bacteri
conjunct
often
compromis
prior
use
empir
antibacteri
therapi
sexual
activ
patient
present
bacteri
conjunct
aggress
diagnost
workup
gram
stain
cultur
risk
neisseria
gonorrhoea
conjunct
sightthreaten
infect
result
perfor
globe
develop
world
trachoma
form
conjunct
due
specif
strain
chlamydia
trachomati
lead
caus
blind
especi
children
offlabel
use
commerci
naat
assay
use
detect
agent
research
set
certain
organ
part
indigen
skin
mucou
membran
microflora
coagulas
neg
staphylococci
corynebacterium
spp
viridan
streptococci
gener
consid
nonpathogen
recov
conjunctiv
mucosa
consid
normal
flora
specimen
taken
surfac
interior
eye
organ
along
propionibacterium
acn
consid
pathogen
especi
patient
postcataract
lasik
surgeri
adenoviru
etiolog
agent
pink
eye
highli
transmiss
varieti
set
almost
alway
clinic
diagnosi
although
epidemiolog
purpos
cultur
naat
done
case
neonat
conjunct
due
either
neisseria
gonorrhoea
chlamydia
trachomati
herp
simplex
viru
commerci
naat
n
gonorrhoea
c
trachomati
fda
approv
specimen
type
cultur
case
c
trachomati
direct
fluoresc
antibodi
test
avail
use
corneal
infect
usual
occur
distinct
patient
popul
ocular
trauma
foreign
object
postsurg
complic
corneal
surgeri
patient
practic
poor
hygien
associ
extend
wear
contact
lens
corneal
infect
also
result
reactiv
herp
virus
includ
herp
simplex
viru
varicella
zoster
viru
postvaccin
kerat
wellrecogn
complic
vaccinia
vaccin
consid
appropri
clinic
set
import
note
use
dye
topic
anesthet
may
inhibit
naat
reaction
use
diagnos
kerat
eye
surfac
thoroughli
rins
nonbacteriostat
salin
specimen
naat
obtain
tabl
common
corneal
infect
occur
patient
improperli
use
contact
len
system
patient
usual
treat
antimicrobi
agent
prior
obtain
specimen
bacteri
cultur
ophthalmologist
favor
cultur
contact
len
solut
case
howev
cultur
solut
case
recommend
frequenc
fals
posit
pseudomona
aeruginosa
common
caus
sporad
contact
len
associ
kerat
outbreak
kerat
due
contamin
contact
len
care
solut
recent
report
fusarium
acanthamoeba
postsurg
kerat
infect
frequent
due
either
coagulaseneg
staphylococci
p
acn
set
organ
consid
contamin
potenti
pathogen
kerat
follow
trauma
due
foreign
object
frequent
caus
organ
found
environ
includ
group
environment
gramneg
rod
p
aeruginosa
nocardia
spp
mould
includ
dematic
fungi
environment
mycobacteria
endophthalm
aris
either
exogen
introduct
pathogen
eye
follow
trauma
surgeri
result
endogen
introduct
pathogen
across
bloodey
barrier
depend
mode
pathogenesi
spectrum
caus
agent
vari
tabl
specimen
diagnosi
endophthalm
obtain
aspir
aqueou
vitreou
fluid
via
biopsi
specimen
amount
small
discret
must
exercis
determin
agent
specimen
examin
postop
endophthalm
often
caus
gramposit
organ
coagulaseneg
staphylococci
predomin
chronic
postop
endophthalm
due
p
acn
organ
dismiss
contamin
environment
organ
dematiac
fungi
fusarium
spp
bacillu
cereu
nocardia
spp
mycobacterium
chelona
glucos
ferment
gramneg
rod
commonli
encount
patient
exogen
endophthalm
endogen
endophthalm
associ
bacteremia
fungemia
usual
caus
organ
respons
bloodstream
infect
eg
candida
albican
relat
speci
aspergillu
spp
aureu
pneumonia
enterobacteriacea
especi
klebsiella
pneumonia
pseudomona
aeruginosa
virus
parasit
rare
found
caus
endophthalm
howev
case
trauma
sever
immunosuppress
infect
due
agent
herp
virus
toxoplasma
gondii
toxocara
spp
echinococcu
spp
onchocerca
volvulu
occur
typic
involv
uvea
retina
inform
diagnosi
ocular
infect
caus
onchocerca
volvulu
see
section
xvc
inflamm
characterist
uveitisretin
typic
due
either
autoimmun
condit
idiopath
infrequ
due
infect
almost
alway
caus
endogen
microb
access
eye
via
breach
bloodey
barrier
uveiti
retin
like
endogen
endophthalm
local
manifest
system
infect
diagnosi
etiolog
system
infect
coupl
care
ocular
examin
perform
prefer
ophthalmologist
specif
infecti
diseas
expertis
import
caus
uveitisretin
includ
toxoplasma
gondii
cytomegaloviru
hsv
vzv
mycobacterium
tuberculosi
treponema
pallidum
gondii
common
infecti
caus
retin
diagnosi
typic
made
clinic
ground
support
serolog
industri
world
presenc
gondii
igg
lack
specif
diagnosi
ocular
toxoplasmosi
therefor
serolog
valuabl
set
acut
infect
patient
ocular
examin
pathognomon
toxoplasmosi
demonstr
retinochoroid
major
case
comparison
intraocular
antibodi
level
aqueou
humor
serum
found
use
mean
diagnos
ocular
toxoplasmosi
specimen
need
test
obtain
highli
invas
procedur
unlik
techniqu
use
outsid
research
set
naat
blood
vitreou
aqueou
fluid
sensit
intraocular
antibodi
determin
specimen
test
may
easili
obtain
sensit
naat
rang
report
patient
gondii
retin
depend
sequenc
use
specimen
test
note
total
number
specimen
test
studi
small
diagnost
valu
naat
gondii
retin
yet
clear
sinc
advent
highli
activ
antiretrovir
treatment
haart
cytomegaloviru
cmv
retin
becom
much
less
frequent
nevertheless
case
occur
hiv
patient
either
fail
hiv
therapi
aidspres
diagnosi
addit
cmv
retin
wellrecogn
complic
bone
marrow
solid
organ
transplant
less
frequent
recent
due
improv
preemptiv
detect
therapi
cmv
retin
frequent
diagnos
clinic
characterist
lesion
seen
ophthalmolog
examin
quantit
cmv
naat
perform
peripher
blood
also
use
tool
diagnosi
manag
infect
patient
detect
cmv
viral
load
higher
likelihood
retin
diseas
progress
high
cmv
viral
load
increas
mortal
patient
undetect
cmv
viral
load
low
likelihood
viru
resist
antivir
agent
interlaboratori
variat
viral
quantif
repres
posit
cmv
viral
load
high
cmv
viral
load
vari
among
laboratori
physician
consult
laboratori
perform
cmv
viral
load
assist
test
interpret
cmv
viral
load
persist
cmv
antigenemia
also
predict
higher
likelihood
retin
diseas
progress
death
patient
syphilit
uveiti
frequent
central
nervou
system
find
either
associ
acut
syphilit
mening
neurosyphili
vdrl
test
cerebrospin
fluid
recommend
clinic
set
syphilit
uveiti
suspect
see
section
iia
otiti
media
singl
frequent
condit
caus
pediatr
patient
taken
healthcar
provid
acut
otiti
media
effus
aom
clinic
variant
otiti
media
like
bacteri
etiolog
result
like
benefit
antimicrobi
therapi
tabl
streptococcu
pneumonia
nontyp
haemophilu
influenza
moraxella
catarrhali
common
bacteri
caus
aom
aureu
streptococcu
pyogen
pseudomona
aeruginosa
occur
less
commonli
alloiococcu
otitidi
also
thought
caus
aom
addit
studi
need
determin
true
signific
organ
varieti
respiratori
virus
known
caus
aom
howev
exist
pathogen
specif
therapi
result
littl
reason
attempt
establish
etiolog
diagnosi
patient
viral
etiolog
effort
determin
caus
aom
best
reserv
patient
like
bacteri
etiolog
recent
onset
bulg
tympan
membran
pain
exud
respond
prior
cours
antimicrobi
therapi
patient
immunolog
defici
acut
ill
patient
repres
specimen
middl
ear
fluid
obtain
either
tympanocentesi
patient
otorrhoea
myringotomi
tube
collect
drainag
minitip
swab
directli
clean
ear
canal
cultur
pharynx
nasopharynx
anterior
nare
nasal
drainag
materi
valu
attempt
establish
etiolog
diagnosi
bacteri
aom
virus
often
etiolog
agent
microbiolog
studi
help
treatment
decis
etiolog
agent
sinus
vari
base
upon
durat
symptom
whether
communityacquir
nosocomi
origin
tabl
streptococcu
pneumonia
nontyp
haemophilu
influenza
moraxella
catarrhali
common
bacteri
caus
acut
maxillari
sinus
role
respiratori
virus
sinus
need
studi
staphylococcu
aureu
gramneg
bacilli
streptococcu
spp
anaerob
bacteria
associ
frequent
subacut
chronic
nosocomi
sinus
role
fungi
etiolog
agent
controversi
possibl
due
numer
public
use
poor
sampl
collect
method
thu
recov
fungal
agent
immunocompet
host
fungi
associ
often
chronic
sinus
sinus
due
fungal
infect
sever
immunocompromis
person
uncontrol
diabet
patient
often
sever
carri
high
mortal
rate
attempt
establish
etiolog
diagnosi
sinus
typic
reserv
patient
complic
infect
chronic
diseas
swab
recommend
collect
sinu
specimen
aspir
much
product
true
etiolog
agent
endoscop
obtain
swab
recov
bacteri
pathogen
rare
detect
caus
fungi
maxillari
sinus
antral
punctur
sinu
aspir
adult
swab
materi
drain
middl
meatu
obtain
endoscop
guidanc
repres
adequ
specimen
cultur
middl
meatu
drainag
specimen
recommend
pediatr
patient
due
potenti
colon
respiratori
tract
pathogen
examin
nasal
drainag
materi
valu
attempt
determin
caus
maxillari
sinus
surgic
procedur
necessari
obtain
specimen
repres
infect
frontal
sphenoid
ethmoid
sinus
establish
fungal
etiolog
endoscop
sinu
aspir
recommend
pharyng
account
estim
million
visit
adult
medic
facil
annual
unit
state
condit
occur
even
often
children
differ
epidemiolog
variou
infecti
agent
relat
age
patient
season
year
accompani
sign
symptom
presenc
absenc
system
diseas
suffici
precis
permit
establish
definit
etiolog
diagnosi
clinic
epidemiolog
ground
alon
consequ
result
laboratori
test
play
central
role
guid
therapeut
decis
tabl
antimicrobi
therapi
warrant
patient
pharyng
proven
bacteri
etiolog
streptococcu
pyogen
group
streptococcu
common
bacteri
caus
pharyng
carri
potenti
seriou
sequela
primarili
children
left
undiagnos
inadequ
treat
sever
laboratori
test
includ
cultur
rapid
antigen
test
molecular
method
use
establish
etiolog
diagnosi
pharyng
due
organ
past
decad
rapid
antigen
test
pyogen
particular
use
extens
evalu
patient
pharyng
test
technic
nondemand
gener
reliabl
often
perform
pointofcar
method
accuraci
clinic
relev
depend
appropri
sampl
techniqu
gener
consensu
among
profession
societi
neg
rapid
antigen
test
pyogen
children
confirm
cultur
molecular
assay
although
gener
necessari
neg
test
result
adult
new
guidelin
suggest
either
convent
cultur
confirm
neg
rapid
antigen
test
result
cultur
use
achiev
maxim
sensit
diagnosi
pyogen
pharyng
adult
laboratori
accredit
colleg
american
pathologist
requir
back
neg
rapid
antigen
test
cultur
role
nongroup
streptococci
particular
group
c
g
caus
pharyng
controversi
howev
mani
healthcar
provid
consid
organ
signific
base
therapeut
decis
detect
rare
case
poststreptococc
glomerulonephr
infect
speci
report
therefor
includ
guidanc
detect
group
c
g
streptococci
larg
coloni
produc
sinc
anginosu
group
characterist
yield
pinpoint
coloni
caus
pharyng
pharyng
swab
specimen
indic
done
set
organ
consid
signific
outbreak
epidemiolog
associ
case
pharyng
recoveri
organ
multipl
patient
outbreak
investig
arcanobacterium
haemolyticum
also
caus
pharyng
less
commonli
occur
often
teenag
young
adult
often
found
caus
highli
suggest
scarlatinaform
rash
patient
neisseria
gonorrhoea
corynebacterium
diphtheria
specif
epidemiolog
set
may
also
caus
pharyng
respiratori
virus
common
caus
pharyng
adult
pediatr
popul
howev
unnecessari
defin
specif
etiolog
patient
pharyng
due
respiratori
virus
exist
pathogendirect
therapi
agent
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
epsteinbarr
viru
ebv
may
also
caus
pharyng
epidemiolog
clinic
implic
infect
due
hsv
hiv
ebv
circumst
may
aris
import
attempt
determin
individu
patient
infect
caus
one
agent
recent
studi
shown
relationship
fusobacterium
necrophorum
pharyng
patient
case
throat
infect
could
prelud
lemierr
syndrom
f
necrophorum
anaerob
organ
requir
addit
media
use
anaerob
isol
identif
procedur
laboratori
prepar
use
throat
specimen
notifi
laboratori
suspect
diagnosi
etiolog
agent
appropri
procedur
avail
absenc
anaerob
capabl
laboratori
would
sent
refer
laboratori
tabl
list
etiolog
agent
diagnost
approach
acut
bronchiti
acut
exacerb
chronic
bronchiti
bronchiol
clinic
syndrom
involv
inflamm
tracheobronchi
tree
acut
bronchiti
larg
due
viral
pathogen
less
frequent
caus
mycoplasma
pneumonia
chlamydophila
pneumonia
bordetella
pertussi
consid
adolesc
young
adult
promin
cough
direct
fluoresc
antibodi
test
replac
nucleic
acid
amplif
test
naat
combin
cultur
recommend
test
choic
b
pertussi
detect
current
one
fda
clear
platform
b
pertussi
detect
streptococcu
pneumonia
haemophilu
influenza
play
establish
role
acut
bronchiti
along
moraxella
catarrhali
figur
promin
case
acut
exacerb
chronic
bronchiti
bronchiol
almost
exclus
caus
virus
pneumonia
sever
fdaapprov
naat
platform
avail
detect
select
respiratori
virus
diagnosi
communityacquir
pneumonia
base
presenc
specif
symptom
suggest
radiograph
featur
pulmonari
infiltr
andor
pleural
effus
care
obtain
microbiolog
data
support
diagnosi
often
fail
provid
etiolog
agent
tabl
list
common
caus
communityacquir
pneumonia
less
common
etiolog
may
need
consid
depend
upon
recent
travel
histori
exposur
vector
anim
transmit
zoonot
pathogen
sin
nombr
viru
hantaviru
pulmonari
syndrom
yersinia
pesti
pneumon
plagu
endem
western
us
rational
attempt
establish
etiolog
identif
pathogen
focu
antibiot
manag
particular
patient
addit
identif
certain
pathogen
legionella
speci
influenza
virus
agent
bioterror
import
public
health
signific
current
idsaat
practic
guidelin
consid
diagnost
test
option
patient
hospit
patient
requir
admiss
pretreat
blood
cultur
cultur
gram
stain
goodqual
sampl
expector
sputum
diseas
sever
urinari
antigen
test
pneumonia
legionella
pneumophila
avail
laboratori
must
mechan
place
screen
sputum
sampl
accept
exclud
heavili
contamin
oropharyng
flora
repres
deepli
expector
sampl
prior
set
routin
bacteri
cultur
poorqual
specimen
provid
mislead
result
reject
interpret
would
compromis
endotrach
aspir
bronchoscop
obtain
sampl
includ
mini
bal
use
combicath
kol
bio
medic
instrument
chantilli
va
similar
technolog
may
requir
hospit
patient
intub
unabl
produc
adequ
sputum
sampl
thoracentesi
perform
patient
pleural
effus
recent
fda
approv
biofir
salt
lake
citi
ut
film
array
nucleic
acid
amplif
test
naat
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
laboratori
develop
naat
assay
current
serolog
test
still
consid
gold
standard
agent
although
like
chang
mycobacteri
infect
differenti
diagnosi
communityacquir
pneumonia
cap
fail
respond
therapi
typic
cap
pathogen
mycobacterium
tuberculosi
declin
unit
state
recent
year
still
import
pathogen
among
immigr
popul
mycobacterium
avium
complex
also
import
among
patient
hiv
patient
chronic
lung
diseas
cystic
fibrosi
middleag
elderli
thin
women
healthcareassoci
hcap
hospitalacquir
pneumonia
hap
ventilatorassoci
vap
pneumonia
frequent
caus
multidrugresist
gramneg
bacteria
bacteri
pathogen
asid
respiratori
virus
may
nosocomi
transmit
virus
fungi
rare
caus
hcap
ha
vap
immunocompet
patient
tabl
list
organ
commonli
associ
pneumonia
immunocompromis
patient
two
diagnost
strategi
recommend
american
thorac
societi
infecti
diseas
societi
america
clinic
strategi
base
presenc
new
lung
infiltr
plu
presenc
clinic
featur
fever
leukocytosi
leucopenia
purul
secret
determin
caus
pneumonia
reli
initi
gram
stain
semiquantit
cultur
endotrach
aspir
sputum
smear
lack
inflammatori
cell
cultur
absent
potenti
pathogen
high
neg
predict
valu
cultur
endotrach
aspir
like
contain
true
pathogen
also
consist
grow
mixtur
speci
bacteria
specimen
obtain
bronchoscop
techniqu
may
lead
addit
unnecessari
antibiot
therapi
bacteriolog
strategi
use
quantit
cultur
lower
respiratori
tract
secret
obtain
either
bronchoscop
via
endotrach
aspir
without
bronchoscop
quantiti
bacteri
growth
threshold
diagnost
pneumonia
quantiti
threshold
consist
colon
gener
accept
threshold
follow
endotrach
aspir
cfuml
bal
cfuml
protect
specimen
brush
sampl
psb
cfuml
valu
signific
sampl
obtain
hour
initi
chang
antibiot
therapi
quantit
studi
requir
extens
laboratori
work
special
procedur
smaller
laboratori
may
accommod
bronchial
wash
appropri
routin
bacteri
cultur
infecti
caus
pleural
effus
shift
tradit
pneumonia
pathogen
pneumonia
pyogen
polymicrobi
infect
anaerob
bacteria
play
major
role
tabl
summar
major
pathogen
signific
accumul
fluid
pleural
space
sampl
thoracentesi
specimen
hand
carri
immedi
laboratori
place
appropri
anaerob
transport
media
transport
institut
bedsid
inocul
blood
cultur
bottl
becom
establish
practic
accept
provid
manufactur
guidelin
follow
respect
volum
inocul
whether
supplement
requir
enhanc
recoveri
fastidi
pathogen
pneumonia
blood
cultur
bottl
use
addit
sampl
sent
microbiolog
laboratori
gram
stain
cultur
nonbacteri
pathogen
indic
fluid
sent
cell
count
ph
protein
glucos
lactat
dehydrogenas
ldh
valu
assist
determin
transud
exud
process
subsequ
manag
syndrom
exampl
follow
paramet
suggest
need
drainag
ph
glucos
mgdl
ldh
iul
presenc
polymorphonuclear
leucocyt
pmn
infect
result
exud
pmn
empyema
within
pleural
caviti
tuberculosi
fungal
pathogen
thought
like
caus
pleural
biopsi
sent
cultur
histopatholog
increas
diagnost
sensit
alway
notifi
laboratori
suspicion
tuberculosi
appropri
safeti
precaut
employ
elev
adenosin
deaminas
level
pleural
fluid
iul
patient
appropri
risk
factor
tuberculosi
shown
high
sensit
high
preval
region
level
iul
exclud
diagnosi
marker
lymphocyt
differenti
use
conjunct
hematolog
chemic
paramet
diagnost
test
naat
cultur
histolog
pleural
biopsi
perform
assay
develop
countri
shown
quit
variabl
relat
multipl
factor
includ
type
method
use
likelihood
tuberculosi
fals
posit
result
patient
caus
lymphocyt
pleural
effus
rheumatoid
diseas
mesothelioma
histoplasmosi
patient
cystic
fibrosi
cf
suffer
chronic
lung
infect
due
disrupt
exocrin
function
allow
clear
microorgan
enter
distal
airway
lung
limit
number
organ
implic
chronic
infect
tabl
earli
childhood
infect
caus
organ
frequent
seen
noncf
pediatr
popul
pneumonia
h
influenza
aureu
point
later
childhood
adolesc
p
aeruginosa
becom
import
pathogen
involv
chronic
lung
infect
concomit
lung
destruct
follow
p
aeruginosa
strain
adapt
hypox
stress
retain
mucoid
secret
convert
biofilm
mode
growth
mucoid
coloni
nosocomi
pathogen
maltophilia
achromobact
xylosoxidan
may
acquir
hospit
clinic
visit
burkholderia
cepacia
complex
import
pathogen
patient
b
cepacia
genomovar
iii
b
cenocepacia
highli
pathogen
respons
rapid
declin
death
subset
patient
acquir
virul
clone
special
microbiolog
techniqu
requir
recov
differenti
b
cepacia
complex
mucoid
p
aeruginosa
strain
less
common
gramneg
organ
appear
increas
frequenc
recoveri
whose
role
pathogenesi
cf
lung
diseas
still
unclear
includ
b
gladioli
ralstonia
spp
cupriavidu
spp
pandorea
cf
patient
surviv
adulthood
opportunist
pathogen
nontubercul
mycobacteria
isol
increas
frequenc
evid
suggest
abscessu
avium
complex
contribut
lung
destruct
treat
cultur
repeatedli
posit
mycobacteri
cultur
ad
routin
cultur
obtain
patient
older
year
age
present
exacerb
incid
mycobacterium
speci
like
underestim
due
failur
routin
assess
patient
organ
aspergillu
fumigatu
common
fungu
recov
cf
patient
caus
primarili
allerg
bronchopulmonari
diseas
scedosporium
apiospermum
may
caus
similar
syndrom
exophiala
dermatitidi
report
center
caus
chronic
colon
cf
airway
trichosporon
mycotoxinivoran
newli
recogn
pathogen
propens
caus
diseas
patient
cystic
fibrosi
tabl
summar
organ
like
caus
exacerb
pulmonari
symptom
cf
patient
number
environment
nonfer
gramneg
bacilli
frequent
recov
sputum
patient
role
cf
lung
diseas
either
unknown
time
unlik
signific
organ
includ
tabl
laboratori
spend
resourc
pathogen
proven
like
play
signific
role
pulmonari
declin
patient
advanc
cancer
treatment
transplant
immunolog
therapi
autoimmun
diseas
hiv
expand
popul
sever
immunocompromis
patient
pulmonari
infect
common
syndrom
contribut
sever
morbid
mortal
among
group
patient
virtual
potenti
pathogen
may
result
signific
ill
challeng
clinician
microbiologist
rapidli
differenti
infecti
noninfecti
caus
pulmonari
infiltr
likelihood
specif
infect
may
affect
recent
administ
prophylaxi
tabl
focus
major
infecti
etiolog
like
interest
immunocompromis
host
patient
still
vulner
usual
bacteri
viral
caus
cap
hap
addit
fungi
herpesvirus
protozoa
play
signific
role
consid
rapid
noninvas
test
urin
serum
antigen
test
rapid
viral
diagnost
reveal
definit
procedur
sampl
lung
requir
sever
diagnost
procedur
perform
usual
patient
initi
undergo
bronchoscopi
bronchoalveolar
lavag
without
transbronchi
biopsi
suggest
microbiolog
laboratori
collabor
infecti
diseas
physician
pulmonologist
develop
algorithm
process
sampl
includ
test
major
categori
pathogen
summar
tabl
cytolog
analysi
andor
histopatholog
often
need
interpret
signific
posit
naat
cultur
herpesvirus
exampl
definit
diagnos
filament
fungi
note
howev
histopatholog
alon
sensit
enough
diagnos
fungal
infect
accompani
immunostain
cultur
avail
naat
addit
serum
bal
galactomannan
serum
test
may
help
howev
cytolog
histopatholog
quit
use
distinguish
condit
pulmonari
hemorrhag
reject
infecti
caus
infiltr
transthorac
needl
aspir
ctguid
biopsi
pleuralbas
lesion
open
lung
likewis
may
consid
less
invas
diagnost
unrev
esophag
often
caus
noninfecti
condit
gastroesophag
reflux
diseas
infecti
caus
often
seen
patient
impair
immun
tabl
calcofluor
potassium
hydroxid
koh
gram
stain
esophag
brush
histopatholog
examin
viral
cultur
esophag
biopsi
establish
diagnosi
case
invas
noninvas
test
tabl
avail
aid
diagnosi
h
pylori
infect
major
infecti
etiolog
gastriti
invas
test
gram
stain
cultur
endoscopi
tissu
histopatholog
stain
direct
test
ureas
requir
collect
biopsi
sampl
obtain
endoscopi
patient
receiv
antimicrobi
agent
proton
pump
inhibitor
week
prior
collect
pose
greater
risk
patient
advantag
noninvas
assay
urea
breath
test
stool
antigen
determin
patient
avoid
endoscopi
gastric
biopsi
also
use
test
organ
erad
therapi
urea
breath
test
perform
clinic
patient
ingest
cocktail
contain
urea
minut
later
breath
sampl
obtain
analyz
presenc
indic
presenc
h
pylori
stomach
assay
sensit
approxim
compar
invas
assay
stool
antigen
test
report
sensit
sensit
higher
adult
children
noninvas
assay
also
use
test
organ
erad
therapi
urea
breath
test
somewhat
higher
sensit
stool
antigen
detect
serodiagnosi
lower
sensit
specif
use
test
cure
therapi
gi
infect
encompass
wide
varieti
symptom
recogn
infecti
agent
tabl
appropri
diagnost
approach
diarrheal
ill
determin
patient
age
sever
diseas
durat
type
ill
time
year
geograph
locat
fecal
test
indic
sever
bloodi
febril
dysenter
nosocomi
persist
diarrheal
ill
commun
laboratori
requir
determin
organ
method
screen
paramet
includ
part
routin
enter
pathogen
cultur
laboratori
abil
cultur
salmonella
shigella
campylobact
test
clostridium
difficil
shiga
toxinproduc
escherichia
coli
consult
laboratori
pathogen
suspect
special
media
may
requir
specimen
choic
diarrheal
stool
ie
take
shape
contain
naat
test
develop
eventu
first
test
choic
current
one
commerci
panel
receiv
fda
clearanc
although
individu
shigatoxin
naat
avail
stool
cultur
stool
cultur
indic
detect
invas
bacteri
enter
pathogen
laboratori
employ
cultur
techniqu
routin
detect
salmonella
shigella
campylobact
recent
shiga
toxinproduc
e
coli
stool
submit
cultur
salmonella
spp
take
hour
recov
identifi
genu
alon
specif
serotyp
usual
perform
state
public
health
laboratori
level
recommend
test
detect
shiga
toxin
test
specif
detect
shiga
toxinproduc
e
coli
shiga
toxinproduc
serotyp
includ
part
routin
test
howev
set
test
may
requir
specif
request
test
detect
e
coli
detect
increas
number
isol
report
may
detect
e
coli
screen
algorithm
limit
test
bloodi
stool
may
also
miss
isol
detect
vibrio
yersinia
unit
state
usual
special
request
requir
addit
media
incub
condit
commun
laboratori
necessari
laboratori
report
indic
enter
pathogen
would
detect
laboratori
encourag
provid
enter
pathogen
isol
public
health
laboratori
andor
center
diseas
control
prevent
pulsedfield
gel
analysi
nation
surveil
purpos
multipl
stool
specimen
rare
indic
detect
stool
pathogen
studi
adult
patient
submit
specimen
enter
pathogen
detect
first
sampl
time
second
specimen
bring
posit
rate
pediatr
patient
first
specimen
detect
enter
pathogen
thu
sampl
children
second
select
adult
patient
may
consid
rectal
swab
less
sensit
stool
specimen
recommend
adult
symptomat
pediatr
patient
rectal
swab
stool
cultur
equival
abil
detect
fecal
pathogen
clostridium
botulinum
botul
intox
protein
exotoxin
botulinum
toxin
produc
clostridium
botulinum
caus
lifethreaten
flaccid
paralysi
diagnosi
usual
confirm
hospit
microbiolog
laboratori
made
clinic
criteria
allow
prompt
initi
essenti
antitoxin
therapi
microbiolog
diagnosi
depend
detect
botulinum
toxin
serum
patient
wound
infant
foodborn
diseas
stool
patient
infant
foodborn
diseas
gastric
contentsvomitu
patient
foodborn
diseas
toxin
detect
perform
mani
state
public
health
laboratori
center
diseas
control
prevent
cultur
perform
fece
wound
yield
low
laboratori
lack
necessari
expertis
isol
identifi
organ
clostridium
difficil
numer
method
employ
laboratori
diagnosi
infect
caus
clostridium
difficil
toxigen
cultur
probabl
sensit
specif
assay
detect
c
difficil
slow
labor
intens
routin
perform
commun
hospit
set
compar
toxigen
cultur
cytotoxin
assay
sensit
cytotoxin
assay
requir
hour
also
labor
intens
thu
toxin
detect
either
enzym
immunoassay
eia
immunochromatograph
method
perform
assay
report
sensit
significantli
faster
result
avail
hour
util
assay
detect
toxin
toxin
b
improv
sensit
avail
naat
assay
eia
toxin
alon
longer
recommend
standalon
assay
nucleic
acid
amplif
assay
detect
c
difficil
avail
consid
test
choic
diagnosi
enterocol
due
c
difficil
report
sensit
reduc
turnaround
time
cost
laboratori
may
employ
algorithm
use
rapid
screen
test
glutam
dehydrogenas
gdh
antigen
without
toxin
b
detect
follow
cytotoxin
naat
confirm
indic
naat
test
employ
gdh
antigen
toxin
screen
result
agre
algorithm
allow
rapid
report
neg
specimen
sensit
cytotoxin
test
naat
could
result
delay
diagnosi
rang
hour
day
depend
laboratori
test
platform
employ
diarrheal
stool
specimen
form
stool
rectal
swab
requir
diagnosi
cdifficil
diseas
colon
specimen
loos
enough
take
shape
contain
form
stool
appropri
reject
laboratori
proviso
form
stool
patient
ileu
potenti
toxic
megacolon
note
physician
test
repeat
test
patient
previous
posit
test
cure
appropri
repeat
test
patient
neg
naat
perform
least
day
sinc
increas
c
difficileassoci
diseas
increas
morbid
mortal
report
unit
state
canada
unit
kingdom
epidem
strain
toxinotyp
iii
north
american
pfge
type
pcrribotyp
carri
binari
toxin
gene
cdta
cdtb
bp
delet
tcdc
produc
toxin
toxin
b
commerci
avail
fdaclear
naat
binari
toxin
tcdc
delet
gene
identifi
strain
epidemiolog
purpos
sever
diseas
believ
due
toxin
hyperproduct
associ
binari
toxin
diseas
sever
controversi
parasit
number
specimen
submit
parasitolog
examin
may
controversi
subject
histor
use
convent
microscop
procedur
recommend
specimen
collect
day
period
submit
ova
parasit
p
examin
option
costeffect
test
today
includ
examin
second
specimen
first
neg
patient
remain
symptomat
third
specimen
submit
patient
continu
p
neg
symptomat
target
use
immunoassay
test
common
parasit
base
geographi
patient
demograph
physician
request
also
use
screen
neg
patient
continu
symptom
patient
specif
risk
factor
requir
full
p
examin
immunoassay
giardia
sensit
enough
singl
specimen
may
need
specimen
preserv
employ
often
suppli
laboratori
depend
need
perform
immunoassay
procedur
special
stain
specimen
manufactur
recommend
specimen
fix
polyvinyl
alcohol
pva
gold
standard
howev
due
presenc
mercur
chlorid
modif
employ
mercuri
develop
none
modifi
preserv
allow
stain
provid
level
microscop
detail
although
experi
accept
altern
routin
procedur
pathogen
e
histolytica
differenti
nonpathogen
e
dispar
use
morpholog
criteria
laboratori
report
may
indic
e
histolyticadispar
immunoassay
naat
differenti
organ
proctiti
commonli
due
sexual
transmit
agent
result
analgenit
contact
although
abscess
perirect
wound
infect
may
present
similar
symptom
one
sampl
usual
suffici
diagnosi
tabl
case
spontan
bacteri
periton
sbp
sourc
invad
organ
unknown
syndrom
also
seen
patient
preexist
risk
factor
cirrhosi
ascit
sbp
tend
monomicrob
caus
aerob
organ
intestin
tract
therefor
anaerob
cultur
less
valuabl
suffici
fluid
eg
ml
avail
obtain
allow
concentr
centrifug
cytospin
gram
stain
evalu
minimum
least
ml
periton
fluid
swab
fluid
collect
asept
transport
laboratori
prior
administr
antimicrobi
agent
addit
laboratori
test
includ
fluid
analysi
protein
cell
count
differenti
lactat
concentr
ph
along
set
blood
cultur
identif
concomit
bacteremia
tabl
altern
sbp
infect
ascit
fluid
tend
monomicrob
aerob
blood
cultur
bottl
inocul
fluid
volum
depend
blood
cultur
system
presenc
singl
organ
reason
certain
gram
stain
may
use
prior
broth
inocul
evalu
morpholog
organ
present
sinc
differenti
sbp
secondari
periton
may
uncertain
may
benefici
submit
periton
fluid
steril
contain
convent
cultur
stain
well
inocul
blood
cultur
bottl
bedsid
fluid
sequenc
pcr
use
identifi
isol
present
specimen
techniqu
avail
laboratori
next
year
next
gener
sequenc
abl
analyz
specimen
determin
total
microbi
load
speci
morpholog
type
note
gram
stain
broth
inocul
caveat
use
blood
cultur
bottl
fluid
blood
system
evalu
purpos
broth
cultur
accur
reflect
bacteri
burden
varieti
organ
time
specimen
obtain
presenc
true
pathogen
may
obscur
overgrowth
rapidli
grow
organ
neg
cultur
result
presenc
indic
infect
prompt
evalu
fastidi
slowli
grow
organ
mycobacterium
spp
fungi
chlamydia
trachomati
neisseria
gonorrhoea
diagnosi
secondari
periton
depend
upon
identifi
sourc
invad
genitourinari
gastrointestin
flora
numer
caus
secondari
periton
includ
iatrogen
accident
trauma
perfor
appendix
diverticuli
typhliti
intraabdomin
abscess
unlik
sbp
howev
secondari
periton
tend
polymicrob
may
includ
anaerob
flora
organ
aureu
n
gonorrhoea
mycobacterium
spp
unusu
set
common
etiolog
includ
aerob
anaerob
gramneg
rod
bacteroid
spp
e
coli
klebsiella
spp
gramposit
flora
clostridium
spp
enterococcu
spp
bifidobacterium
spp
peptostreptococcu
spp
typhliti
suspect
c
difficil
toxin
test
stool
cultur
enter
pathogen
blood
cultur
request
addit
c
septicum
consid
neutropen
enterocol
periton
fluid
sent
laboratori
anaerob
transport
system
gram
stain
aerob
anaerob
bacteri
cultur
inocul
blood
cultur
bottl
alon
periton
fluid
appropri
set
competit
bacteri
growth
broth
cultur
could
mask
recoveri
clinic
import
pathogen
tabl
cytomegaloviru
cmv
possibl
caus
secondari
periton
microbiolog
laboratori
contact
arrang
special
process
cmv
concern
microbiolog
laboratori
also
contact
n
gonorrhoea
concern
sinc
special
process
naat
specimen
type
fdaclear
commerci
platform
test
necessari
polymicrob
natur
secondari
periton
clinician
expect
request
identif
suscept
test
organ
isol
rather
laboratori
provid
gener
descript
cultur
result
eg
mix
aerob
anaerob
intestin
flora
select
identif
certain
organ
mrsa
streptococcu
spp
multidrugresist
gramneg
bacilli
vre
etc
guid
empir
antimicrobi
therapi
patient
respond
convent
therapi
addit
specimen
collect
examin
resist
organ
presenc
intraabdomin
abscess
entiti
refer
persist
recurr
periton
follow
unsuccess
treatment
secondari
periton
tertiari
periton
might
also
indic
presenc
intraabdomin
abscess
organ
refractori
broad
spectrum
antimicrobi
therapi
vancomycinresist
enterococcu
spp
candida
speci
pseudomona
aeruginosa
biofilmproduc
bacteria
like
coagulaseneg
staphylococcu
spp
fluid
cultur
case
tertiari
periton
commonli
neg
bacteria
case
cultur
appropri
spontan
secondari
periton
may
help
tabl
possibl
infect
caus
unusu
slowli
grow
organ
filament
fungi
mycobacterium
spp
entertain
bacteri
cultur
neg
growth
cultur
result
growth
mycobacterium
spp
may
repres
dissemin
diseas
howev
afb
parasit
studi
would
rare
consid
evalu
dialysi
fluid
patient
suspect
pdap
essenti
ident
use
sbp
infect
tend
monomicrob
rare
anaerob
case
pdap
howev
list
like
suspect
organ
quit
differ
sbp
gramposit
bacteria
predominantli
staphylococcu
spp
lesser
extent
streptococcu
corynebacterium
spp
account
cultur
microorgan
gramneg
bacteria
mostli
e
coli
klebsiella
enterobact
spp
repres
posit
cultur
anaerob
compris
isol
fungi
especi
candida
speci
contribut
number
identifi
infect
anaerob
cultur
remain
neg
case
pdap
ml
dialys
collect
concentr
cultur
cytospin
gram
stain
evalu
analysi
protein
cell
count
differenti
tabl
blood
cultur
rare
posit
case
pdap
direct
inocul
dialys
concentr
dialys
aerob
blood
cultur
bottl
autom
detect
proven
effect
direct
plate
centrifug
fluid
consult
directli
microbiolog
laboratori
primari
cultur
fluid
neg
addit
cultur
slowli
grow
highli
fastidi
organ
mycobacterium
nocardia
filament
fungi
pursu
nocardia
concern
primari
cultur
plate
requir
prolong
incub
cultur
fungal
media
buffer
charcoal
yeast
extract
agar
primari
diagnost
dilemma
case
spaceoccupi
lesion
liver
distinguish
caus
parasit
entamoeba
histolytica
echinococcu
pyogen
abscess
caus
bacteria
fungi
locat
size
number
liver
abscess
often
help
differenti
purpos
major
right
lobe
seen
singl
multipl
loci
region
e
histolytica
diseas
endem
use
serolog
serum
antigen
detect
test
help
exclud
ameb
abscess
wherea
examin
stool
cyst
trophozoit
gener
tabl
liver
abscess
aspir
test
presenc
ehistolytica
antigen
well
submit
direct
microscop
evalu
parasit
ameb
diseas
unlik
abscess
aspir
content
submit
anaerob
transport
aerob
anaerob
bacteri
cultur
commonli
recov
isol
includ
klebsiella
spp
e
coli
enterobacteriacea
pseudomona
spp
streptococcu
spp
includ
streptococcu
anginosu
group
spp
enterococcu
spp
viridan
group
streptococcu
aureu
bacteroid
spp
fusobacterium
spp
especi
lemierr
syndrom
clostridium
spp
rare
candida
spp
aerob
anaerob
bacteri
cultur
request
tabl
blood
cultur
also
help
establish
etiolog
collect
prior
institut
antimicrobi
therapi
occasion
patient
primari
genit
infect
due
n
gonorrhoea
c
trachomati
extens
diseas
involv
liver
capsul
adjac
peritoneum
fitzhughcurti
syndrom
unexpectedli
bacteria
commonli
associ
biliari
tract
infect
primarili
cholecyst
cholang
organ
recov
case
pyogen
liver
abscess
see
tabl
parasit
caus
includ
ascari
clonorchi
spp
parasit
inhabit
biliari
tree
lead
obstruct
minimum
cultur
aerob
bacteria
anaerob
aspir
collect
appropri
gram
stain
request
sign
sepsi
periton
present
blood
periton
cultur
obtain
well
patient
hiv
infect
list
potenti
agent
subsequ
microbiolog
evalu
need
expand
includ
cryptosporidium
microsporidia
cystoisospora
isospora
belli
cmv
mycobacterium
avium
complex
identif
organ
requir
special
process
import
commun
laboratori
determin
test
avail
either
onsit
refer
laboratori
case
splenic
abscess
result
metastat
contigu
infecti
process
trauma
splenic
infarct
immunosuppress
infect
like
aerob
monomicrob
staphylococcu
spp
streptococcu
spp
enterococcu
spp
salmonella
spp
e
coli
commonli
isol
anaerob
bacteria
recov
cultureposit
case
aspir
process
similar
manner
pyogen
liver
abscess
includ
aerob
anaerob
cultur
gram
stain
concomitantli
collect
blood
cultur
set
tabl
unusu
caus
splenic
abscess
includ
bartonella
spp
streptobacillu
moniliformi
nocardia
spp
burkholderia
pseudomallei
uncommon
outsid
southeast
asia
without
suggest
travel
histori
laboratori
notifi
agent
possibl
due
need
increas
biosafeti
precaut
sinc
b
pseudomallei
potenti
bioterror
agent
biliari
diseas
spectrum
organ
consid
need
expand
includ
mycobacterium
spp
fungi
includ
pneumocysti
jirovecii
parasit
immunocompromis
patient
case
acut
chronic
pancreat
produc
obstruct
autoimmun
alcohol
ingest
necrot
pancreat
tissu
gener
one
process
serv
nidu
infect
infecti
agent
associ
acut
pancreat
numer
divers
howev
superinfect
pancrea
often
caus
gastrointestin
flora
e
coli
klebsiella
spp
member
enterobacteriacea
enterococcu
spp
staphylococcu
spp
streptococcu
spp
candida
spp
necrot
tissu
pancreat
aspir
sent
aerob
bacteri
cultur
gram
stain
accompani
set
blood
cultur
tabl
antimicrobi
suscept
result
isol
organ
use
direct
therapi
reduc
likelihood
pancreat
sepsi
extens
infect
contigu
organ
mortal
steril
cultur
necrot
pancreat
tissu
unusu
may
trigger
consider
expand
search
fastidi
slowli
grow
organ
parasit
virus
establish
etiolog
diagnosi
osteomyel
nearli
alway
requir
obtain
bone
biopsi
materi
microbiolog
evalu
much
specimen
possibl
desir
specimen
may
includ
piec
intact
bone
shave
scrape
excis
necrot
materi
true
osteomyel
bone
tissu
often
necrot
easili
obtain
curett
swab
cultur
sinu
tract
diagnost
recommend
similarli
determin
etiolog
joint
infect
usual
requir
sampl
joint
space
directli
aspir
synovi
fluid
andor
biopsi
synovium
concomit
secondari
bacteremia
fungemia
occur
sporad
patient
osteomyel
infect
joint
although
patient
contigu
spread
osteomyel
rare
develop
bacteremia
blood
cultur
rare
appropri
popul
thu
blood
cultur
collect
febril
episod
recommend
evalu
patient
suspect
secondari
bacteremia
fungemia
assess
acut
phase
reactant
nonspecif
marker
inflamm
procalcitonin
creactiv
protein
erythrocyt
sediment
rate
diagnost
patient
infect
may
yield
help
inform
therapi
less
common
agent
may
requir
molecular
detect
method
often
need
sent
refer
laboratori
ensu
longer
turnaround
time
result
tabl
addit
spontan
hematogen
seed
joint
infect
tabl
special
categori
exist
prosthet
joint
infect
especi
infect
knee
hip
prosthes
often
caus
coagulaseneg
staphylococci
laboratori
diagnosi
prosthet
joint
infect
base
perisurg
cultur
difficult
sinc
contamin
skin
organ
uncommon
surgic
sampl
import
chang
fresh
steril
scalpel
make
initi
incis
one
recommend
differenti
true
coagulaseneg
staphylococc
infect
contamin
occur
surgic
remov
tissu
surround
prosthet
joint
obtain
separ
small
tissu
biopsi
curet
surgic
procedur
speci
recov
sampl
strong
evid
pathogen
presurg
sampl
joint
fluid
suspect
infect
perform
manner
acut
arthriti
tabl
european
public
document
rapid
hour
pre
perisurg
identif
aureu
mrsa
put
methicillinresist
coagulas
neg
staphylococci
joint
fluid
use
rapid
naat
assay
intraop
gram
stain
poor
yield
posit
may
help
shoulder
joint
whether
natur
prosthet
preferenti
infect
propionibacterium
acn
normal
commens
skin
organ
anaerob
cultur
shoulder
tissu
biopsi
incub
anaerob
broth
day
discard
neg
recent
work
primarili
mayo
clinic
recommend
sonic
prosthet
joint
biopsi
sampl
cultur
postson
fluid
anoth
recent
techniqu
found
increas
yield
bacteria
perhap
yeast
joint
tissu
bone
remov
prosthet
revis
surgeri
bead
mill
process
use
mm
glass
bead
sinc
fungi
mycobacteria
extrem
rare
set
sought
without
special
commun
laboratori
fungi
suspect
bead
mill
method
would
like
destroy
hyphal
element
minc
bone
tissu
direct
inocul
onto
fungal
agar
still
recommend
sonic
bead
mill
process
avail
laboratori
clinic
microbiolog
test
valu
establish
etiolog
diagnosi
infect
urinari
tract
cover
section
includ
specimen
laboratori
procedur
diagnosi
cystiti
pyelonephr
prostat
epididym
orchiti
special
test
avail
smaller
laboratori
may
sent
refer
laboratori
expect
longer
turnaround
time
result
idsa
guidelin
diagnosi
treatment
urinari
tract
infect
publish
asm
recommend
provid
diagnost
recommend
similar
present
tabl
differenti
cystiti
pyelonephr
requir
clinic
inform
physic
find
well
laboratori
inform
laboratori
perspect
spectrum
pathogen
similar
two
syndrom
cultur
urin
test
posit
pyuria
either
dipstick
test
leukocyt
esteras
indic
pmn
may
increas
likelihood
posit
cultur
occasion
sampl
yield
posit
screen
test
yield
neg
cultur
result
vice
versa
gram
stain
appropri
method
detect
pmn
urin
order
option
detect
high
number
gramneg
rod
patient
suspect
suffer
urosepsi
urin
easili
contamin
commens
flora
specimen
cultur
bacteri
urinari
tract
pathogen
collect
attent
minim
contamin
perin
superfici
mucos
microbiota
although
literatur
suggest
tradit
skin
cleans
prepar
collect
midstream
clean
catch
specimen
benefit
mani
laboratori
find
specimen
obtain
without
skin
cleans
routin
contain
mix
flora
store
properli
transport
within
one
hour
laboratori
yield
high
number
one
potenti
pathogen
cultur
interpret
cultur
difficult
skin
cleans
still
recommend
use
urin
transport
media
vacuumfil
tube
refriger
immedi
collect
may
decreas
prolifer
small
number
contamin
organ
increas
number
interpret
result
straight
inandout
catheter
properli
prepar
patient
usual
provid
less
contamin
specimen
mix
enter
bacteria
high
number
recov
second
wellcollect
straightcatheter
sampl
patient
rectalurinari
fistula
consid
laboratori
action
base
decis
arriv
dialogu
clinician
laboratori
specimen
urinari
cathet
place
hour
frequent
contain
colon
flora
due
rapid
biofilm
format
cathet
surfac
may
repres
infect
cultur
indwel
cathet
therefor
strongli
discourag
requir
specimen
taken
sampl
port
newli
insert
devic
cultur
foley
cathet
tip
clinic
valu
reject
collect
specimen
urinari
divers
ileal
loop
also
discourag
propens
locat
chronic
colon
chronic
nephrostomi
collect
bag
urin
collect
also
question
valu
multipl
organ
coagulaseneg
staphylococci
may
recov
patient
urinari
stent
may
pathogen
import
urologist
nephrologist
care
patient
complic
infect
discuss
special
need
request
microbiolog
director
supervisor
specimen
patient
may
contain
mix
flora
specif
interpret
criteria
document
specimen
type
laboratori
must
awar
document
special
interpret
standard
laboratori
routin
provid
antimicrobi
suscept
test
potenti
pathogen
signific
number
specimen
obtain
invas
mean
cystoscop
suprapub
aspir
clearli
identifi
workup
discuss
advanc
laboratori
especi
clinician
interest
recoveri
bacteria
concentr
less
coloni
form
unit
cfu
per
millilit
identif
singl
potenti
pathogen
number
low
cfuml
may
signific
acut
urethr
syndrom
request
cultur
result
report
cfuml
coordin
laboratori
appropri
volum
urin
proces
recoveri
yeast
usual
candida
spp
even
high
cfuml
infrequ
patient
actual
yeast
uti
thu
interpret
cultur
yield
yeast
standard
bacteri
pathogen
yeast
urin
may
rare
indic
system
infect
addit
test
must
conduct
confirm
eg
blood
cultur
level
recoveri
mycobacterium
tuberculosi
best
accomplish
firstvoid
morn
specimen
ml
requir
specif
request
laboratori
appropri
process
media
employ
recoveri
adenoviru
case
cystiti
requir
specif
request
viral
cultur
nucleic
acid
amplif
test
naat
may
also
avail
refer
laboratori
detect
adenoviru
polyoma
bk
viru
nephropathi
best
diagnos
quantit
molecular
determin
circul
viru
blood
rather
detect
viru
urin
test
usual
perform
refer
laboratori
acut
bacteri
prostat
defin
clinic
sign
physic
find
combin
posit
urin
prostat
secret
cultur
yield
usual
urinari
tract
pathogen
diagnosi
chronic
prostat
much
problemat
percentag
case
posit
cultur
obtain
much
lower
tradit
mearesstamey
four
glass
specimen
obtain
collect
first
ml
void
midstream
specimen
express
prostat
secret
ep
ml
postprostatemassag
urin
posit
ten
fold
higher
bacteri
count
ep
midstream
urin
twospecimen
variant
involv
midstream
ep
specimen
also
use
posit
test
infrequ
chronic
pelvic
pain
syndrom
frequent
caus
cultur
infecti
agent
rememb
prostat
massag
patient
acut
bacteri
prostat
may
precipit
bacteremia
andor
shock
tabl
summar
approach
laboratori
diagnosi
prostat
epididym
men
year
age
frequent
associ
sexual
transmit
pathogen
chlamydia
trachomati
neisseria
gonorrhoea
naat
sensit
rapid
diagnost
procedur
agent
commerci
avail
system
collect
kit
cultur
n
gonorrhoea
recommend
antibiot
resist
concern
special
media
requir
antimicrobi
suscept
test
ast
may
refer
public
health
laboratori
men
year
age
gramneg
gramposit
pathogen
similar
organ
caus
uti
prostat
may
caus
invas
infect
epididymi
testi
surgic
obtain
tissu
may
cultur
bacteri
pathogen
ast
perform
fungal
mycobacteri
diseas
uncommon
laboratori
diagnosi
requir
commun
clinician
laboratori
ensur
proper
medium
select
process
particularli
tissu
cultur
organ
bacteri
orchiti
may
caus
gramneg
gramposit
pathogen
frequent
extens
contigu
infect
epididymi
viral
orchiti
frequent
ascrib
mump
viru
diagnosi
made
igm
serolog
mump
antibodi
acut
convalesc
igg
serolog
viral
caus
epididymoorch
coxsacki
viru
rubella
viru
epsteinbarr
viru
varicellazost
viru
system
fungal
diseas
involv
epididymi
testi
includ
blastomycosi
histoplasmosi
coccidioidomycosi
mycobacterium
tuberculosi
may
also
involv
site
tabl
summar
approach
specimen
manag
case
epididym
orchiti
genit
lesion
may
multipl
simultan
infecti
etiolog
make
challeng
diagnos
treat
properli
center
diseas
control
prevent
cdc
guidelin
recommend
patient
present
genit
lesion
evalu
serolog
test
syphili
well
diagnost
test
genit
herp
h
ducreyi
chancroid
preval
mani
genit
lesion
exhibit
inflammatori
epithelium
enhanc
transmiss
hiv
screen
eia
enzymeimmunoassay
hiv
antibodi
test
recommend
patient
well
tabl
show
diagnost
test
identifi
etiolog
common
genit
lesion
suspect
case
hsv
genit
lesion
viral
cultur
direct
fluoresc
antibodi
dfa
andor
nucleic
acid
amplif
test
naat
commonli
use
diagnosi
sinc
method
specif
test
vesicl
vari
among
laboratori
consult
laboratori
specimen
collect
appropri
instanc
naat
sensit
especi
suboptim
collect
nonulc
vesicular
lesion
may
present
may
limit
specimen
sourc
accept
patient
age
depend
naat
use
cultur
like
posit
patient
vesicular
versu
ulcer
lesion
specimen
obtain
first
episod
lesion
versu
recurr
lesion
specimen
immunosuppress
patient
rather
immunocompet
dfa
allow
assess
adequ
specimen
rapid
test
perform
onsit
isol
type
determin
sinc
recurr
rate
common
serolog
distinguish
unless
typespecif
glycoprotein
g
gg
assay
request
point
care
test
poct
may
yield
fals
posit
result
patient
popul
low
likelihood
hsv
infect
earli
stage
infect
well
fals
neg
result
primari
lesion
due
children
present
genit
lesion
provid
assum
hsv
consid
potenti
atyp
present
varicella
zoster
viru
vzv
dfa
best
detect
vzv
cultur
less
sensit
pregnant
patient
histori
genit
herp
assess
activ
lesion
time
deliveri
new
consensu
guidelin
manag
women
abnorm
cervic
cytolog
lesion
human
papilloma
viru
hpv
well
use
genotyp
test
pend
public
consensu
guidelin
discuss
american
journal
obstetr
gynecolog
wright
et
al
regard
routin
highrisk
hpv
test
avail
websit
wwwasccporgconsensushistologicalshtml
access
recent
american
societi
colposcopi
cervic
patholog
asccp
hpv
genotyp
updat
discuss
test
specif
hpv
genotyp
women
basic
hpv
test
recommend
purpos
triag
women
year
age
atyp
squamou
cell
undetermin
signific
ascu
asch
atyp
squamou
cell
exclud
high
grade
squamou
intraepitheli
lesion
hsil
test
highrisk
hpv
type
associ
cervic
cancer
appropri
followup
test
abnorm
cytolog
andor
posit
hpv
complic
reader
refer
asccp
guidelin
manag
decis
addit
recommend
test
genotyp
hpv
women
high
risk
hpv
test
order
conjunct
cytolog
consid
gener
result
cytolog
neg
hpv
high
risk
posit
warrant
hpv
genotyp
determin
identif
patient
higher
risk
progress
invas
cervic
cancer
endocerv
specimen
liquid
cytolog
medium
higher
sensit
detect
signific
lesion
eg
squamou
intraepitheli
lesion
sil
facilit
subsequ
hpv
test
patient
sinc
done
specimen
patient
cervix
remain
hysterectomi
hiv
posit
patient
patient
receiv
quadrival
recombin
hpv
vaccin
gardasil
merck
co
undergo
routin
papanicola
pap
hpv
screen
manag
pap
andor
hpv
test
postpon
woman
menstruat
unit
state
test
syphili
tradit
consist
initi
screen
inexpens
nontreponem
test
rapid
plasma
reagin
rpr
retest
reactiv
specimen
specif
expens
treponem
test
eg
pallidum
particl
agglutin
tppa
nontreponem
test
use
screen
test
confirm
high
percentag
fals
posit
result
occur
mani
medic
condit
unrel
syphili
test
result
reactiv
indic
present
past
infect
howev
econom
reason
highvolum
clinic
laboratori
begun
use
autom
treponem
test
autom
eia
immunochemoluminesc
test
revers
test
sequenc
first
screen
treponem
test
retest
reactiv
result
nontreponem
test
approach
introduc
complex
test
interpret
exist
tradit
sequenc
specif
screen
treponem
test
sometim
identifi
person
reactiv
treponem
test
nonreact
nontreponem
test
formal
recommend
exist
regard
result
deriv
new
test
sequenc
interpret
patient
result
manag
begin
assess
clinic
laboratori
address
concern
cdc
review
test
algorithm
use
test
interpret
provid
four
laboratori
new
york
citi
substanti
variat
found
test
strategi
use
might
lead
confus
appropri
patient
manag
total
specimen
test
result
ie
reactiv
treponem
test
result
nonreact
nontreponem
test
result
would
identifi
tradit
test
algorithm
obviat
addit
test
nontreponem
test
result
nonreact
previous
treat
patient
reactiv
result
treponem
test
nonreact
result
nontreponem
test
treat
late
latent
syphili
treponema
pallidum
seen
gram
stain
cultur
routin
laboratori
darkfield
exam
motil
spirochet
unavail
major
laboratori
chancroid
caus
gramneg
organ
haemophilu
ducreyi
one
genit
lesion
gram
stain
may
help
diagnosi
commun
laboratori
presum
diagnosi
specimen
transport
may
enhanc
recognit
organ
gram
stain
facilit
appropri
cultur
techniqu
sampl
must
obtain
surfac
debrid
sent
referr
laboratori
familiar
test
mani
microbiologist
rare
seen
chancroid
lymphogranuloma
venereum
lgv
caus
intracellular
pathogen
chlamydia
trachomati
ct
specif
serovar
lgv
diagnosi
exclus
common
entiti
context
epidemiolog
inform
diagnos
bacteri
vaginosi
bv
alter
vagin
flora
vagin
caus
fungal
organ
vulvovagin
candidiasi
vvc
trichomona
vaginali
tv
often
consid
clinic
diagnost
group
overlap
natur
howev
mode
transmiss
andor
acquisit
necessarili
sti
bv
vvc
tv
number
pointofcar
test
poct
perform
vagin
discharg
specimen
patient
healthcar
set
although
poct
popular
sensit
specif
poct
make
specif
diagnosi
vari
wide
assay
rapid
often
diagnost
poor
test
includ
ph
strip
test
score
gram
stain
bv
wet
mount
tv
koh
microscop
examin
vvc
bv
use
clinic
criteria
amsel
diagnost
criteria
equal
score
gram
stain
vagin
discharg
howev
score
gram
stain
specif
probe
hybrid
poct
test
detect
presenc
g
vaginali
hallmark
organ
alter
vagin
flora
vvc
tv
presenc
pseudohypha
motil
trichomonad
respect
allow
diagnosi
howev
profici
microscop
examin
essenti
given
infect
may
mix
andor
present
atyp
manifest
unfortun
consist
microscop
exam
vagin
specimen
interpret
difficult
mani
laboratori
perform
wide
variat
sensit
tv
cvv
use
smear
exam
exist
rel
naat
cultur
respect
note
recent
public
util
naat
highlight
preval
trichomona
equal
greater
ct
gc
point
grow
trend
toward
screen
tv
ct
gc
simultan
test
entiti
vaginosisvagin
shown
tabl
urethr
cervic
share
common
sign
symptom
infecti
etiolog
male
femal
patient
respect
tabl
combin
diagnost
test
use
identifi
pathogen
common
addit
screen
ct
gc
reduc
repercuss
relat
infect
subsequ
pid
follow
guidelin
screen
women
ct
gc
present
us
prevent
servic
task
forc
annual
ct
screen
gc
screen
consid
local
epidemiolog
risk
laboratori
diagnosi
ct
gc
mani
method
exist
nucleic
amplif
test
naat
prefer
assay
detect
increas
sensit
retain
specif
low
preval
popul
pregnant
patient
abil
screen
noninvas
urin
specimen
specif
eia
test
ct
use
due
lack
sensit
gener
retest
patient
followup
test
ct
gc
test
cure
recommend
unless
special
circumst
exist
pregnanc
continu
symptom
howev
patient
higher
risk
sti
screen
within
month
initi
posit
test
possibl
reinfect
patient
repeat
infect
higher
risk
pid
requir
test
practic
andor
need
confirmatori
test
pediatr
patient
may
vari
state
state
appropri
provid
laboratori
perform
test
children
consult
naat
sampl
genit
current
fdaclear
requir
inhous
laboratori
valid
recent
preval
studi
use
naat
shown
trichomona
common
ct
common
gc
clinic
geograph
set
uniqu
high
presenc
women
incarcer
popul
addit
ulcer
natur
infect
lead
sequela
similar
ct
gc
includ
perinat
complic
well
suscept
hiv
hsv
acquisit
transmiss
fdaclear
naat
allow
test
screen
specimen
use
ct
gc
test
significantli
improv
sensit
wet
mount
standard
test
genitalium
avail
recommend
howev
patient
nonchlamydi
ngu
nongonococc
urethr
infect
may
due
organ
naat
may
best
option
detect
genitalium
due
issu
cultur
crossreact
serolog
test
test
neither
fdaclear
wide
avail
cultur
ureaplasma
recommend
high
preval
colon
asymptomat
sexual
activ
peopl
pelvic
inflammatori
diseas
pid
spectrum
disord
upper
femal
genit
tract
includ
singl
combin
endometr
tuboovarian
abscess
salping
pid
clinic
difficult
identifi
patient
present
mild
nonspecif
symptom
find
symptom
physic
exam
cervic
motion
tender
well
criteria
elev
temperatur
mucopurul
discharg
increas
specif
posit
predict
valu
laboratori
test
diagnost
test
depend
clinic
sever
diseas
epidemiolog
risk
assess
whether
invas
procedur
laparoscopi
andor
endometri
biopsi
use
bacteri
test
perform
nonasept
collect
specimen
endocerv
dilat
curettag
c
limit
util
diagnos
pid
actinomyc
spp
caus
infect
associ
intrauterin
devic
suspect
laboratori
notifi
cultur
sampl
anaerob
includ
anaerob
broth
held
day
patient
suspect
pid
test
ct
gc
tv
hiv
difficulti
diagnosi
well
signific
potenti
sequela
make
threshold
therapi
low
postpartum
endometr
suspect
patient
present
high
fever
two
occas
hour
apart
first
hour
deliveri
day
post
deliveri
first
hour
postdeliveri
abdomin
pain
uterin
tender
foul
lochia
usual
multiorgan
syndrom
infect
commonli
seen
patient
unplan
ceaserean
section
inabl
introduc
antibiot
quickli
postpartum
endometr
reduc
test
treat
symptomat
bv
late
pregnanc
associ
preterm
labor
prolong
deliveri
screen
colon
group
b
streptococci
vagin
anal
swab
week
gestat
prophylaxi
labor
deliveri
reduc
incid
neonat
diseas
although
role
cultur
set
endometr
controversi
diagnost
test
consid
diagnosi
pid
postpartum
endometr
shown
tabl
children
sexual
assault
consider
refer
set
clinic
specif
deal
situat
reader
refer
refer
jenni
kellogg
girardet
black
naat
noninvas
specimen
yield
excel
result
msm
typic
genit
site
alway
infect
eg
urethra
urin
recommend
cdc
includ
screen
popul
number
site
gc
ct
includ
rectum
pharynx
urethra
reader
refer
cdc
treatment
guidelin
recommend
pregnant
patient
screen
hiv
syphili
hepat
b
surfac
antigen
hbsag
ct
gc
high
risk
group
high
gc
preval
area
routin
symptomat
patient
vaginosisvagin
test
bv
trichomona
screen
group
b
streptococci
occur
week
rectal
vagin
swab
specimen
submit
optim
identif
carrier
laboratori
typic
use
enrich
broth
select
media
enhanc
recoveri
trichomona
group
b
streptococci
naat
avail
group
b
streptococci
sensit
optim
perform
enrich
broth
specimen
group
streptococci
detect
group
b
pcr
test
past
histori
sti
higher
risk
group
andor
clinic
present
consist
infect
assess
pathogen
warrant
eg
hsv
vesicular
lesion
present
although
rare
listeria
infect
pregnant
woman
usual
acquir
via
ingest
unpasteur
chees
food
pass
fetu
lead
diseas
death
neonat
due
nonspecif
symptom
diagnosi
difficult
blood
cultur
bacterem
mother
may
allow
detect
pathogen
time
antibiot
prophylaxi
screen
test
serolog
stool
cultur
pregnant
women
appropri
relianc
clinic
sign
symptom
alon
diagnosi
burn
wound
infect
challeng
unreli
sampl
burn
wound
either
surfac
swab
tissu
biopsi
cultur
recommend
monitor
presenc
extent
infect
tabl
quantit
cultur
either
specimen
recommend
optim
util
quantit
surfac
swab
requir
twice
weekli
sampl
site
accur
monitor
trend
bacteri
colon
major
limit
surfac
swab
quantit
cultur
microbi
growth
reflect
microbi
flora
surfac
wound
rather
advanc
margin
subcutan
deep
underli
damag
tissu
quantit
bacteri
cultur
tissu
biopsi
supplement
histopatholog
examin
better
ascertain
extent
microbi
invas
advis
quantit
bacteri
cultur
may
offer
laboratori
quantit
biopsi
cultur
consid
patient
graft
necessari
prior
sampl
biopsi
wound
thoroughli
cleans
devoid
topic
antimicrobi
affect
cultur
result
blood
cultur
collect
detect
system
diseas
secondari
wound
applic
nucleic
acid
amplif
test
naat
detect
list
virus
commonli
restrict
blood
andor
bodi
fluid
advis
clinician
determin
local
support
laboratori
valid
assay
laboratori
assess
perform
tissu
specimen
precaut
would
also
appli
molecular
detect
mrsa
except
one
fdaclear
test
aureu
mrsa
ssti
vre
human
oral
caviti
contain
mani
potenti
aerob
anaerob
pathogen
primari
sourc
pathogen
caus
infect
follow
human
bite
common
staphylococcu
spp
streptococcu
spp
clostridium
spp
pigment
anaerob
gramneg
rod
fusobacterium
spp
infect
common
pediatr
age
group
often
inflict
play
abus
adult
bite
wound
vari
superfici
abras
sever
manifest
includ
lymphang
local
abscess
septic
arthriti
tenosynov
osteomyel
rare
complic
includ
endocard
mening
brain
abscess
sepsi
accompani
dissemin
intravascular
coagul
especi
immunocompromis
patient
addit
challeng
acquir
repres
wound
specimen
aerob
anaerob
cultur
major
limit
cultur
potenti
mislead
inform
result
polymicrobi
natur
wound
import
gram
stain
perform
specimen
assess
presenc
indic
inflamm
eg
neutrophil
superfici
contamin
squamou
epitheli
cell
microorgan
swab
specimen
choic
mani
case
tabl
major
limit
swab
versu
tissu
biopsi
aspir
includ
greater
risk
contamin
surfacecolon
flora
limit
quantiti
specimen
acquir
dri
unless
place
appropri
transport
media
dilut
rare
microb
limit
yield
cultur
human
bite
wound
oral
caviti
anim
primari
sourc
potenti
pathogen
thu
anticip
etiolog
agent
highli
depend
upon
type
anim
inflict
bite
tabl
sinc
dog
cat
account
major
animalinflict
bite
wound
two
promin
group
microorgan
initi
consid
evalu
patient
pasteurella
spp
name
p
cani
dog
p
multocida
subspeci
multocida
subspeci
septica
cat
capnocytophaga
canimorsu
common
aerob
includ
streptococci
staphylococci
moraxella
spp
saprophyt
neisseria
spp
anim
bite
wound
often
polymicrobi
natur
includ
varieti
anaerob
due
complex
microbi
flora
anim
examin
cultur
organ
list
tabl
littl
benefit
sinc
organ
includ
commerci
identif
system
convent
autom
data
base
infect
trauma
usual
caus
exogen
environment
microbi
flora
due
individu
endogen
normal
flora
tabl
strongli
recommend
specimen
submit
cultur
within
first
hour
posttrauma
sinc
growth
specimen
collect
within
time
frame
like
repres
environment
flora
acquir
time
trauma
episod
motor
vehicl
accid
stab
gunshot
wound
etc
optim
time
acquir
cultur
immedi
postdebrid
trauma
site
recommend
initi
cultur
focu
common
pathogen
addit
test
reserv
uncommon
rare
infect
associ
special
circumst
ex
detect
vibrio
spp
follow
saltwat
exposur
patient
chronic
manifest
infect
respond
initi
cours
therapi
although
consid
quit
manner
extern
trauma
intraven
drug
user
ivdu
inject
exogen
substanc
may
includ
spore
soil
contamin
caus
skin
soft
tissu
infect
rang
abscess
necrot
fasciiti
agent
similar
tabl
addit
clostridium
sordellii
c
botulinum
caus
wound
botul
agent
human
bite
wound
tabl
among
skin
popper
use
saliva
drug
diluent
surgic
site
infect
ssi
may
caus
endogen
flora
origin
exogen
sourc
healthcar
provid
environ
materi
manipul
incision
organspac
surgic
procedur
incision
infect
divid
superfici
skin
subcutan
tissu
deep
tissu
muscl
fascia
deep
incision
organspac
infect
ssi
associ
highest
morbid
reader
refer
center
diseas
control
prevent
guidelin
prevent
surgic
site
infect
specif
definit
ssi
http
microbi
agent
list
tabl
staphylococcu
aureu
includ
methicillinresist
aureu
mrsa
coagulaseneg
staphylococci
enterococci
isol
nearli
infect
although
nterococc
speci
commonli
isol
superfici
cultur
seldom
true
pathogen
regimen
includ
coverag
enterococci
success
surgic
site
infect
recommend
idsa
therapeut
regimen
surgic
site
infect
reliabl
activ
organ
optim
clinic
relev
laboratori
result
resist
use
swab
surgic
procedur
instead
submit
tissu
fluid
aspir
common
intervent
devic
use
diagnost
therapeut
purpos
includ
intervent
radiolog
surgic
drain
former
consist
minim
invas
procedur
angiographi
balloon
angioplastyst
chemoembol
drain
insert
embol
thrombolysi
biopsi
radiofrequ
ablat
cryoablat
line
insert
inferior
vena
cava
filter
vertebroplasti
nephrostomi
placement
radiolog
insert
gastrostomi
dialysi
access
relat
intervent
transjugular
intrahepat
portosystem
shunt
biliari
intervent
endoven
laser
ablat
varicos
vein
perform
use
imag
guidanc
procedur
regard
either
diagnost
eg
angiogram
perform
treatment
purpos
eg
angioplasti
imag
use
direct
procedur
perform
needl
tini
instrument
eg
cathet
infect
result
procedur
rare
consid
evalu
patient
undergon
intervent
radiolog
constitut
risk
factor
infect
due
invas
natur
procedur
varieti
drainag
devic
use
remov
blood
serum
lymph
urin
pu
fluid
accumul
wound
bed
follow
procedur
eg
fluid
deep
wound
intracorpor
caviti
intraabdomin
postop
abscess
commonli
use
follow
abdomin
cardiothorac
neurosurgeri
orthoped
breast
surgeri
chest
abdomin
drain
also
use
trauma
patient
remov
fluid
accumul
help
prevent
seroma
subsequ
infect
routin
use
postop
surgic
drain
diminish
although
use
certain
situat
quit
necessari
type
drain
use
select
accord
qualiti
quantiti
drainag
fluid
amount
suction
requir
anatom
locat
anticip
amount
time
drain
need
tube
may
also
tailor
accord
aforement
specif
type
tube
includ
round
flat
silicon
rubber
blakechannel
triplelumen
sump
mechan
drainag
may
depend
graviti
bulb
suction
may
requir
hospit
wall
suction
portabl
suction
devic
drain
may
left
place
one
day
week
remov
infect
suspect
infecti
organ
may
colon
drain
tube
typic
depend
anatom
locat
posit
drain
superfici
intraperiton
within
organ
duct
fistula
indic
use
intrepret
cultur
result
drain
place
day
may
difficult
due
presenc
colon
bacteria
yeast
drain
character
graviti
lowpressur
bulb
evacu
spring
reservoir
low
pressur
high
pressur
fluid
drain
optim
specimen
collect
submiss
microbiolog
laboratori
fluid
collect
asept
transport
laboratori
appropri
devic
blood
cultur
bottl
aerob
steril
leak
proof
contain
ie
urin
cup
citratecontain
blood
collect
tube
prevent
clot
event
blood
present
expect
pathogen
graviti
drain
origin
skin
gi
tract
remain
drain
type
skin
flora
repres
predomin
pathogen
presenc
fungi
mould
yeast
skin
pose
challeng
clinician
determin
repres
contamin
saprophyt
colon
true
clinic
infect
conveni
fungi
list
type
mycosi
produc
tabl
eg
dermatophyt
typic
produc
tinea
ringworm
type
infect
dematiac
darkli
pigment
mould
yeastlik
fungi
caus
cutan
subcutan
form
mycosi
dimorph
fungi
gener
caus
system
mycosi
presenc
cutan
lesion
signifi
either
dissemin
primari
direct
inocul
infect
yeastlik
fungi
usual
agent
opportunistictyp
mycos
also
manifest
primari
dissemin
diseas
true
opportunist
mould
eg
aspergillu
spp
fusarium
spp
addit
recommend
optim
specimen
associ
cultur
fungal
serolog
test
complement
fixat
immunodiffus
perform
parallel
independ
often
benefici
diagnos
agent
system
mycosi
specif
caus
histoplasma
coccidioid
case
activ
histoplasmosi
blastomycosi
urin
antigen
test
may
valu
identifi
dissemin
diseas
clinician
awar
dematiac
fungi
name
appear
darkli
pigment
laboratori
media
alway
appear
pigment
tissu
rather
hyalin
natur
help
differenti
dematiac
speci
fontana
mason
stain
histopatholog
perform
detect
small
quantiti
melanin
produc
fungi
uncommon
group
fungi
mistakenli
misidentifi
histolog
hyalin
mould
aspergillu
spp
highlight
import
correl
cultur
result
histolog
observ
determin
clinic
relev
sinc
observ
fungal
element
histopatholog
specimen
like
indic
activ
fungal
invas
clinic
microbiolog
test
valu
establish
etiolog
variou
tickborn
diseas
present
tabl
borrelia
speci
respons
relaps
fever
lyme
borreliosi
diseas
transmit
tick
human
lyme
borreliosi
multisystem
diseas
affect
skin
nervou
system
joint
heart
infect
frequent
report
tickborn
diseas
northern
hemispher
part
earli
lyme
diseas
diagnos
clinic
ground
includ
presenc
erythema
migran
earlydissemin
latepersist
lyme
diseas
diagnos
twotier
serolog
test
eia
follow
western
blot
western
blot
perform
except
reflex
test
initi
eia
return
posit
equivoc
igm
western
blot
clinic
interpret
patient
week
symptom
western
blot
igg
igm
base
test
igg
band
igm
band
criteria
posit
least
igg
band
least
igm
band
plu
posit
equivoc
eia
posttreat
lyme
diseas
syndrom
may
occur
appropri
antibiot
therapi
laboratori
document
b
burgdorferi
infect
persist
symptom
last
six
month
fatigu
musculoskelet
pain
neurocognit
dysfunct
perman
respond
longterm
antibiot
therapi
base
randomizedcontrol
trial
data
rickettsi
diseas
transmit
tick
includ
rocki
mountain
spot
fever
human
granulocytotrop
anaplasmosi
human
monocytotrop
ehrlichiosi
other
includ
caus
ehrlichia
ewingii
although
clinic
similar
diseas
epidemiolog
etiolog
distinct
ill
diagnosi
patient
infect
challeng
earli
cours
clinic
infect
sinc
sign
symptom
often
nonspecif
mimic
benign
viral
ill
addit
lyme
borreliosi
rickettsi
diseas
babesiosi
colorado
tick
fever
viru
also
transmit
tick
sinc
organ
transmit
tick
infrequ
encount
clinic
specimen
clinic
microbiolog
laboratori
provid
servic
list
tabl
signific
tick
born
relaps
fever
ehrlichiosi
anaplasmosi
babesiosi
rapidli
diagnos
examin
peripher
blood
smear
howev
neg
smear
result
necessarili
rule
tick
born
diseas
due
often
low
variabl
sensit
peripher
blood
smear
examin
organ
therefor
clinic
specimen
cultur
molecular
analysi
major
serolog
assay
part
sent
refer
laboratori
addit
naat
diseas
list
fdaclear
test
univers
avail
limit
avail
perform
variou
test
format
ie
cultur
molecular
analysi
major
serolog
assay
provid
need
check
laboratori
avail
test
optimum
test
approach
appropri
specimen
sourc
turnaround
time
rna
viru
genom
consist
three
major
gene
encod
capsid
protein
gag
revers
transcriptas
proteas
integras
pol
envelop
glycoprotein
env
hiv
virus
classifi
base
related
genom
sequenc
type
group
clade
protein
differ
molecular
weight
categor
group
nonm
nono
n
p
common
common
us
latter
consid
person
born
travel
receiv
blood
product
sexual
partner
west
africa
well
similarli
expos
person
geograph
area
antibodi
detect
acut
hiv
infect
usual
within
first
four
week
follow
exposur
preced
posit
antigen
turn
preced
three
five
day
hiv
rna
posit
perform
hiv
rna
test
neg
initi
antibodi
andor
antigen
test
person
suspect
acut
infect
may
therefor
help
time
cours
test
posit
possibl
seroneg
laboratori
diagnosi
primari
acut
infect
usual
base
high
quantit
rna
viral
load
result
typic
copiesml
qualit
detect
rna
andor
provir
dna
tabl
outsid
set
acut
hiv
infect
howev
hiv
viral
load
assay
use
caution
diagnosi
hiv
infect
possibl
fals
posit
result
fals
posit
result
gener
low
copi
number
copiesml
therefor
low
copi
number
result
prompt
retest
second
specimen
notabl
period
infect
marker
detect
test
anoth
specimen
two
four
week
later
consid
initi
antibodi
antigen
rna
test
neg
naat
sensit
individu
establish
hiv
infect
due
viral
suppress
either
natur
therapeut
improp
specimen
collectionhandl
naat
use
make
diagnosi
acut
infect
may
help
document
subsequ
seroconvers
convent
serolog
test
neonat
serolog
test
unreli
due
persist
matern
antibodi
quantit
rna
viral
load
test
sensit
qualit
rna
andor
provir
dna
test
diagnosi
infect
serolog
diagnosi
evolv
sinc
first
second
gener
assay
indirect
eia
use
viral
lysat
recombinantsynthet
peptid
antigen
respect
third
gener
assay
allow
detect
hiv
igm
addit
igg
enabl
earlier
diagnosi
infect
incorpor
hiv
antigen
detect
allow
even
earlier
diagnosi
infect
third
fourth
gener
assay
gener
posit
seven
four
seven
day
respect
detect
viru
naat
hiv
antigen
may
detect
serum
plasma
day
infect
antibodi
becom
detect
typic
decreas
detect
limit
thereaft
limit
util
antigen
test
alon
combin
hiv
antibodi
plu
assay
ie
fourth
gener
assay
widespread
use
initi
screen
assay
associ
public
health
laboratori
center
diseas
control
prevent
recommend
initi
screen
test
diagnosi
hiv
infect
test
algorithm
associ
use
requir
western
blot
instead
individu
reactiv
result
test
antibodi
immunoassay
distinguish
antibodi
differenti
assay
neg
test
qualit
quantit
naat
recommend
rule
acut
infect
differenti
assay
posit
viral
load
test
usual
also
determin
recommend
direct
manag
altern
approach
initi
hiv
antigenantibodi
combin
assay
discrimin
detect
antigen
antibodi
reactiv
subsequ
confirm
naat
antibodi
reactiv
differenti
assay
tradit
laboratori
diagnosi
nonacut
infect
tabl
begin
screen
antibodi
test
screen
assay
show
reactiv
result
confirmatori
test
western
blot
perform
altern
naat
test
second
antibodi
differ
antigen
constitu
base
differ
consid
initi
posit
hiv
antibodi
immunoassay
use
oral
fluid
specimen
follow
immunoassay
perform
blood
serum
plasma
posit
result
follow
naat
supplement
antibodi
test
corrobor
infect
neg
blood
serum
plasma
result
requir
followup
test
previous
describ
use
tradit
algorithm
western
blot
result
posit
patient
consid
infect
neg
test
antibodi
recommend
rule
possibl
infect
caus
reactiv
combin
antibodi
result
western
blot
test
unread
ie
due
high
background
reactiv
strip
test
antibodyspecif
indirect
immunofluoresc
assay
qualit
quantit
test
rna
provir
dna
consid
accord
associ
public
health
laboratori
center
diseas
control
prevent
antibodi
western
blot
result
interpret
posit
least
follow
band
present
one
band
present
result
indetermin
addit
supplement
test
antibodyspecif
indirect
immunofluoresc
assay
eia
antibodi
alon
qualit
rna
andor
provir
dna
assay
consid
caus
indetermin
western
blot
includ
evolv
antibodi
profil
specimen
contamin
antibodi
declin
immun
system
failur
late
stage
infect
nonspecif
reactiv
due
viral
cellular
protein
compon
infect
eg
syphili
retrovirus
parasit
immunemodul
condit
eg
pregnanc
infect
group
n
p
highrisk
patient
reactiv
serolog
screen
test
result
indetermin
western
blot
neg
supplement
test
consid
retest
two
four
week
later
resolv
issu
addit
supplement
test
eg
naat
may
consid
western
blot
assay
less
sensit
third
fourth
gener
eia
seroconvers
three
week
follow
posit
fourth
gener
assay
posit
western
blot
assay
sinc
mani
third
healthi
hivuninfect
blood
donor
indetermin
western
blot
assay
order
first
test
hiv
line
immunoassay
incorpor
recombin
protein
andor
synthet
peptid
compar
purifi
protein
separ
electrophoresi
use
western
blot
altern
western
blot
assay
resist
test
recommend
patient
acut
chronic
hiv
infect
prior
initi
therapi
includ
pregnant
women
virolog
failur
combin
drug
therapi
suboptim
suppress
viral
load
initi
therapi
epsteinbarr
viru
caus
mononucleosi
lymphoprolif
diseas
immunocompromis
patient
elev
white
blood
cell
count
increas
percentag
atyp
lymphocyt
common
ebvassoci
mononucleosi
heterophil
antibodi
usual
becom
detect
sixth
tenth
day
follow
symptom
onset
increas
second
third
week
ill
thereaft
gradual
declin
year
longer
falseposit
result
may
found
patient
leukemia
pancreat
carcinoma
viral
hepat
cmv
infect
etc
falseneg
result
obtain
approxim
patient
especi
common
children
younger
year
rapid
monospot
heterophil
test
result
neg
addit
laboratori
test
tabl
may
consid
differenti
ebv
infect
mononucleosislik
ill
caus
cmv
adenoviru
hiv
toxoplasma
gondii
etc
situat
ebv
antibodi
test
igg
igm
viral
capsid
antigen
vca
epsteinbarr
nuclear
antigen
ebna
recommend
presenc
vca
igm
without
vca
igg
antibodi
absenc
antibodi
ebna
indic
recent
primari
infect
ebv
presenc
ebna
antibodi
indic
infect
week
time
sampl
therefor
like
implic
ebv
caus
antibodi
ebna
develop
one
two
month
primari
infect
detect
life
normal
adult
popul
igg
class
antibodi
vca
ebna
antigen
although
approxim
patient
infect
ebv
fail
develop
antibodi
ebna
antigen
ebv
associ
lymphoprolif
diseas
patient
congenit
acquir
immunodefici
includ
patient
sever
combin
immunodefici
recipi
organ
peripher
blood
stem
cell
transplant
patient
infect
hiv
increas
ebv
viral
load
detect
naat
peripher
blood
may
present
patient
develop
ebvassoci
lymphoprolif
diseas
level
typic
decreas
effect
therapi
tissu
patient
ebvassoci
lymphoprolif
diseas
may
show
monoclon
oligoclon
polyclon
lesion
diagnosi
ebvassoci
lymphoprolif
diseas
requir
demonstr
ebv
dna
rna
protein
biopsi
tissu
naat
may
use
detect
ebv
dna
csf
patient
acquir
immunodefici
syndromerel
central
nervou
system
lymphoma
howev
ebv
dna
may
also
present
cerebrospin
fluid
abnorm
eg
central
nervou
system
toxoplasmosi
pyogen
brain
abscess
therefor
posit
nonspecif
detect
antibodi
csf
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
calcul
csf
serum
antibodi
index
may
help
immunocompet
individu
suspect
acut
cmv
infect
test
cmvspecif
antibodi
recommend
first
line
laboratori
diagnost
test
tabl
immunocompet
host
presenc
igm
class
antibodi
indic
recent
infect
howev
fals
posit
cmv
igm
result
may
occur
patient
infect
ebv
activ
immun
system
due
caus
presenc
igg
antibodi
alon
indic
past
exposur
cmv
recipi
organ
peripher
blood
stem
cell
transplant
cmv
viral
load
naat
antigenemia
perform
fewer
laboratori
naat
gain
favor
use
marker
preemptiv
therapi
diagnos
cmvassoci
sign
symptom
monitor
respons
antivir
therapi
standard
refer
materi
srm
avail
nation
institut
standard
technolog
nist
cmv
viral
load
measur
srm
consist
bacteri
artifici
chromosom
contain
genom
town
strain
cmv
use
assign
number
amplifi
genom
copi
cmvvolum
eg
copiesmicrolit
cytomegaloviru
cultur
peripher
blood
mononuclear
cell
clinic
specimen
howev
isol
laborintens
take
day
wait
time
shorten
day
use
shell
vial
assay
addit
long
turnaround
time
culturebas
assay
poor
sensit
viral
load
typic
high
cmv
shed
urin
newborn
urin
cultur
cmv
continu
use
institut
diagnosi
congenit
cmv
infect
cytomegaloviru
antigen
demonstr
immunohistochem
situ
hybrid
test
formalinfix
paraffinembed
tissu
cytomegaloviru
dna
detect
use
naat
varieti
clinic
specimen
may
use
diagnos
cmv
diseas
among
immunocompromis
patient
cmv
infect
potenti
exist
emerg
resist
antivir
agent
varieti
assay
use
assess
antivir
resist
commonli
sequenc
phosphotransferas
gene
without
dna
polymeras
gene
util
situat
sequencingbas
assay
perform
dna
amplifi
directli
clinic
specimen
provid
contain
suffici
quantiti
cmv
dna
altern
viru
first
isol
cell
cultur
ganciclovir
resist
commonli
emerg
due
point
mutat
delet
foscarnet
cidofovir
unaffect
mutat
three
codon
common
point
mutat
delet
occur
less
frequent
mutat
select
ganciclovir
cidofovir
typic
crossresist
ganciclovir
cidofovir
foscarnet
mutat
select
foscarnet
usual
crossresist
ganciclovir
cidofovir
naat
may
use
detect
cmv
dna
csf
patient
suspect
cmvcentral
nervou
system
infect
fals
posit
result
may
occur
eg
patient
bacteri
mening
cmv
dna
blood
cross
inflam
bloodbrain
barrier
contamin
cerebrospin
fluid
detect
antibodi
cerebrospin
fluid
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
calcul
csf
serum
cmv
antibodi
index
may
help
presenc
vzv
igg
igm
typic
indic
recent
infect
vzv
howev
result
may
also
observ
patient
recent
immun
vzv
posit
vzv
igg
neg
vzv
igm
result
indic
previou
exposur
vzv
andor
respons
vaccin
neg
igg
result
coupl
neg
igm
result
indic
absenc
prior
exposur
vzv
immun
rule
vzv
infect
specimen
may
drawn
appear
detect
antibodi
neg
result
suspect
earli
vzv
infect
follow
test
new
serum
specimen
two
three
week
sensit
specif
test
diagnosi
vzvassoci
skin
lesion
naat
tabl
cultur
transport
swab
vigor
rub
base
suspect
skin
lesion
vesicl
may
unroof
expos
base
less
sensit
method
diagnosi
detect
viral
antigen
direct
fluoresc
antibodi
stain
lesion
scrape
vzv
cultur
recommend
sinc
viru
difficult
grow
routin
cell
line
may
take
two
week
isol
unless
use
shell
vial
assay
suspect
vzvassoci
skin
lesion
must
clinic
differenti
smallpox
describ
algorithm
develop
center
diseas
control
prevent
http
wwwbtcdcgovagentsmallpoxdiagnosisriskalgorithmindexasp
inform
laboratori
test
smallpox
avail
http
wwwbtcdcgovagentsmallpoxlabtest
vzv
naat
perform
csf
aid
diagnosi
vzv
central
nervou
system
infect
csf
igm
intrathec
antibodi
synthesi
distinguish
meningoenceph
postinfecti
immunemedi
process
presenc
igg
antibodi
specif
glycoprotein
g
antigen
hsv
type
indic
previou
exposur
correspond
serotyp
viru
posit
igg
result
differenti
past
current
activ
infect
unless
seroconvers
determin
test
parallel
acut
convalesc
phase
specimen
fourfold
increas
igg
result
may
also
suggest
recent
exposur
howev
commerci
assay
longer
yield
titer
result
use
quantit
presenc
igm
antibodi
hsv
suggest
activ
primari
infect
viru
naat
sensit
specif
rapid
test
diagnosi
hsvassoci
skin
mucos
lesion
detect
distinguish
hsv
type
tabl
viral
cultur
transport
swab
vigor
rub
base
suspect
skin
mucos
lesion
vesicl
may
unroof
expos
base
older
dri
scab
lesion
less
like
yield
posit
result
cultur
direct
fluoresc
antibodi
test
less
sensit
naat
hsv
naat
perform
csf
use
diagnos
hsv
central
nervou
system
diseas
assay
detect
distinguish
hsv
type
type
commonli
associ
enceph
type
mening
viral
cultur
cerebrospin
fluid
insensit
diagnosi
hsv
central
nervou
system
diseas
human
herp
caus
roseola
infantum
children
caus
primari
reactiv
infect
immunocompromis
patient
igg
seroconvers
demonstr
igm
fourfold
rise
igg
antibodi
pair
sera
may
indic
recent
infect
commerci
assay
typic
distinguish
variant
b
ubiquit
natur
peopl
expos
viru
two
year
age
therefor
singl
igg
serolog
test
result
may
clinic
relev
five
percent
asymptomat
adult
may
igm
posit
given
time
commonli
use
molecular
test
laboratori
diagnosi
naat
none
fdaclear
format
differenti
variant
b
tabl
naat
differenti
replic
latent
viru
dna
quantif
may
use
regard
well
monitor
respons
antivir
therapi
may
shed
intermitt
healthi
immunocompromis
host
therefor
detect
blood
bodi
fluid
even
tissu
definit
establish
diagnosi
diseas
caus
chromosom
integr
hhv
result
high
level
whole
blood
may
lead
erron
diagnosi
activ
infect
cultur
peripher
blood
mononuclear
cell
clinic
specimen
howev
viral
isol
laborintens
take
day
detect
time
shorten
day
shell
vial
cultur
assay
addit
long
process
time
culturebas
assay
suffer
poor
sensit
differenti
variant
b
antigen
demonstr
immunohistochem
situ
hybrid
test
formalinfix
paraffinembed
tissu
immunocompet
individu
erythema
infectiosum
arthralgiaarthr
test
parvoviru
erythroviru
antibodi
recommend
first
line
laboratori
diagnost
method
parvoviru
infect
tabl
presenc
igm
class
antibodi
suggest
recent
infect
igm
antibodi
detect
day
post
infect
may
persist
five
month
occasion
even
longer
igg
igm
reach
peak
titer
within
one
month
igg
antibodi
may
persist
year
presenc
igg
antibodi
alon
indic
past
exposur
suggest
immun
test
may
help
women
first
trimest
pregnanc
serolog
test
may
neg
immunocompromis
host
despit
prior
exposur
viru
parvoviru
dnabas
assay
may
use
diagnosi
parvoviru
infect
present
transient
aplast
crisi
chronic
anemia
immunosuppress
patient
naat
sensit
noninvas
techniqu
laboratori
diagnosi
parvoviru
anemia
solid
organ
transplant
recipi
although
current
test
laboratoryvalid
fdaclear
caveat
regard
naat
diagnosi
parvoviru
anemia
parvoviru
dna
anecdot
detect
extend
period
serum
even
healthi
individu
presenc
giant
pronormoblast
bone
marrow
suggest
parvoviru
infect
although
cell
alway
detect
individu
immun
measl
yield
posit
result
igg
antibodi
viru
immun
neg
igg
igm
result
recent
infect
measl
viru
typic
indic
posit
igm
antibodi
result
absenc
igg
igm
often
posit
day
onset
rash
howev
first
hour
rash
onset
test
igm
may
fals
neg
therefor
acut
igm
neg
second
serum
specimen
collect
hour
rash
onset
test
igm
igm
detect
month
longer
rash
onset
igm
may
posit
individu
recent
immun
measl
viru
serolog
diagnosi
acut
measl
requir
demonstr
fourfold
rise
igg
antibodi
titer
tabl
two
serum
specimen
collect
first
specimen
obtain
soon
possibl
rash
onset
second
specimen
collect
day
later
test
concurr
method
criteria
document
increas
titer
depend
specif
test
use
measur
measlesspecif
antibodi
csf
use
diagnosi
subacut
scleros
panenceph
sspe
level
rubeola
antibodi
highli
elev
cerebrospin
fluid
sspe
patient
compar
without
diseas
measl
viru
isol
throat
nasopharyng
swab
urin
specimen
collect
soon
rash
onset
naat
also
consid
diagnost
test
option
swab
viral
transport
medium
cell
cultur
medium
steril
isoton
solut
eg
salin
sever
type
test
use
mump
diagnosi
tabl
laboratori
criteria
diagnosi
mump
includ
posit
serolog
test
mump
igm
antibodi
fourfold
rise
serum
mump
igg
antibodi
level
acut
convalescentphas
pair
sera
isol
mump
viru
clinic
sampl
detect
mump
rna
clinic
specimen
sera
acut
phase
igg
test
collect
within
day
symptom
onset
ie
time
diagnosi
convalesc
sera
collect
approxim
two
week
symptom
onset
igm
antibodi
typic
becom
detect
first
day
ill
reach
peak
week
onset
receipt
one
dose
mump
vaccin
may
result
absent
delay
transient
igm
respons
acut
igm
neg
second
specimen
collect
igm
test
week
onset
symptom
among
previous
immun
suspect
case
mump
viru
detect
particularli
import
method
confirm
case
prefer
sampl
viral
isol
swab
parotid
duct
duct
anoth
affect
salivari
gland
mump
viru
also
detect
molecular
techniqu
fdaclear
test
mump
viral
rna
may
detect
prior
onset
parot
five
nine
day
onset
detect
antibodi
csf
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
blood
brain
barrier
calcul
csf
serum
antibodi
index
mump
viru
may
help
serolog
common
method
confirm
diagnosi
rubella
tabl
presenc
antibodi
rubella
viru
singl
serum
specimen
evid
immun
acut
rubella
infect
serolog
confirm
fourfold
rise
rubella
igg
antibodi
titer
acut
convalesc
serum
specimen
presenc
serum
rubella
igm
test
perform
serum
collect
earli
possibl
within
day
onset
ill
day
minimum
day
later
caution
taken
interpret
posit
rubella
igm
result
fals
posit
result
occur
rubella
longer
endem
unit
state
therefor
igm
test
perform
patient
clinic
present
suggest
acut
rubella
prenat
screen
rubella
immun
perform
use
iggbas
assay
bk
viru
caus
allograft
nephropathi
renal
transplant
recipi
definit
diagnosi
requir
renal
allograft
biopsi
situ
hybrid
bk
viru
bk
viru
may
also
caus
hemorrhag
cystiti
especi
stem
cell
transplant
recipi
detect
certain
level
bk
viral
load
naat
plasma
may
provid
earli
indic
allograft
nephropathi
although
fdaclear
naat
tabl
urin
cytolog
quantit
naat
may
use
screen
test
follow
bk
viral
load
test
naat
posit
urin
naat
bk
viru
may
sensit
urin
decoy
cell
virusinfect
cell
shed
tubul
urinari
tract
epithelium
detect
bk
viru
dna
may
present
earlier
urin
decoy
cell
howev
urinari
shed
bk
viru
common
occurr
use
screen
test
high
level
ie
laboratori
establish
threshold
correl
diseas
consid
signific
urin
test
bk
viru
place
laboratori
risk
specimen
crosscontamin
extrem
high
level
viru
urin
may
lead
carryov
specimen
fals
posit
result
jc
viru
etiolog
agent
progress
multifoc
leukoencephalopathi
pml
often
fatal
demyelin
diseas
central
nervou
system
occur
immunocompromis
host
histolog
examin
brain
biopsi
tissu
reveal
characterist
patholog
chang
situ
hybrid
jc
viru
may
perform
brain
tissu
detect
jc
viru
dna
naat
csf
specimen
patient
suspect
progress
multifoc
leukoencephalopathi
larg
replac
need
tissu
biopsi
laboratori
diagnosi
tabl
dengu
mosquitoborn
febril
ill
travel
certain
area
chikungunya
yellow
fever
consid
differenti
diagnosi
along
malaria
dengu
diagnosi
requir
laboratori
confirm
cultur
naat
test
dengu
specif
antibodi
tabl
serolog
test
repres
common
method
diagnosi
dengu
infect
acutephas
serum
specimen
collect
within
five
day
onset
fever
patient
earli
stage
dengu
fever
viru
infect
may
detect
igg
antibodi
igg
antibodi
typic
take
least
six
day
onset
symptom
develop
igg
antibodi
dengu
may
persist
decad
neg
test
result
report
patient
dengu
fever
strongli
suspect
second
serum
specimen
drawn
day
diseas
onset
test
igm
igg
antibodi
detect
dengu
igm
may
indic
recent
infect
seroconvers
dengu
igg
also
demonstr
confirm
diagnosi
test
antidengu
antibodi
may
detect
antibodi
flavivirus
includ
west
nile
st
loui
enceph
virus
molecular
test
dengu
viru
avail
upon
special
request
center
diseas
control
prevent
select
refer
laboratori
diagnosi
acut
hepat
viru
infect
confirm
detect
hepat
aspecif
igm
antibodi
tabl
presenc
hepat
virusspecif
total
antibodi
ie
igm
igg
combin
asymptomat
patient
normal
liver
test
indic
either
past
hepat
infect
immun
viral
infect
vaccin
current
commerci
avail
laboratori
test
detect
hepat
aspecif
igg
antibodi
hepat
b
surfac
antigen
may
detect
presenc
acut
chronic
hepat
b
viru
infect
indic
person
infecti
acut
infect
appear
predat
clinic
symptom
four
week
remain
detect
one
six
week
test
hepat
b
diseas
detect
primarili
serolog
molecular
tabl
check
laboratori
minimum
volum
blood
need
molecular
platform
requir
blood
other
presenc
hepat
b
surfac
antibodi
indic
recoveri
immun
hepat
b
infect
result
either
natur
infect
vaccin
patient
selflimit
acut
hepat
b
infect
hepat
b
surfac
antigen
antibodi
detect
simultan
serum
plasma
hepat
b
core
igm
antibodi
appear
acut
recent
hepat
b
viru
infect
remain
detect
six
month
serolog
window
occur
hepat
b
surfac
antigen
disappear
hepat
b
surfac
antibodi
undetect
window
period
infect
diagnos
detect
hepat
b
core
igm
antibodi
remain
detect
six
month
hepat
b
core
total
antibodi
appear
onset
symptom
acut
hepat
b
infect
persist
life
presenc
indic
acut
mainli
virusspecif
igm
antibodi
recent
hepat
b
corespecif
igm
igg
antibodi
previou
hepat
b
corespecif
igg
antibodi
hepat
b
infect
chronic
hepat
b
viru
carrier
state
defin
persist
hepat
b
surfac
antigen
least
week
patient
chronic
hepat
b
infect
presenc
hepat
b
e
antigen
serum
plasma
marker
high
viral
replic
level
liver
loss
hepat
b
e
antigen
emerg
antibodi
hepat
b
e
antigen
usual
associ
improv
underli
hepat
reduct
risk
hepatocellular
carcinoma
cirrhosi
altern
disappear
hepat
b
e
antigen
may
denot
emerg
precor
mutant
viru
high
concentr
hbsag
hbv
dna
absenc
hepat
b
e
antigen
presenc
antibodi
hepat
b
e
antigen
suggest
presenc
precor
mutant
viru
hepat
b
viral
dna
present
serum
plasma
acut
chronic
hepat
b
infect
quantif
hepat
b
viral
dna
pcr
brancheddna
assay
method
may
includ
initi
evalu
manag
chronic
hepat
b
infect
especi
decid
treatment
initi
monitor
patient
respons
therapi
molecular
laboratori
test
use
diagnosi
manag
hepat
b
infect
review
includ
assay
determin
viral
genotyp
detect
genotyp
drug
resist
mutat
core
promoterprecor
mutat
detect
hepat
b
surfac
antibodi
absenc
hepat
b
core
total
antibodi
distinguish
vaccinemedi
immun
immun
acquir
natur
infect
hepat
b
surfac
hepat
b
core
total
antibodi
present
current
commerci
avail
assay
detect
hepat
b
surfac
antibodi
yield
posit
result
qualit
antibodi
level
miuml
serum
plasma
indic
postvaccin
immun
protect
antibodi
level
quantit
hepat
b
surfac
antibodi
result
use
monitor
adequaci
hepat
b
immun
globulin
therapi
liver
transplant
recipi
receiv
therapi
posttranspl
period
acut
hepat
superinfect
patient
known
chronic
hepat
b
hepat
antigen
hepat
dspecif
igm
total
antibodi
present
tabl
acut
hepat
b
coinfect
serolog
marker
ie
hepat
antigen
hepat
dspecif
igm
total
antibodi
present
along
hepat
b
core
igm
antibodi
diagnosi
hcv
usual
begin
screen
test
hcvspecif
igg
antibodi
use
eia
chemiluminesc
immunoassay
cia
antibodi
may
detect
howev
six
ten
week
onset
clinic
ill
individu
neg
screen
test
result
need
test
hcv
tabl
posit
screen
test
result
undergo
confirmatori
supplement
test
hcv
rna
molecular
test
method
signaltocutoff
ratio
calcul
divid
optic
densiti
valu
sampl
test
optic
densiti
valu
assay
cutoff
run
altern
supplement
test
http
wwwcdcgovhepatitishcvlabtestinghtm
hepat
c
viru
rna
detect
naat
soon
infect
well
chronic
infect
naat
hcv
perform
qualit
reversetranscript
pcr
transcriptionmedi
amplif
quantit
reversetranscript
pcr
branch
dna
prior
treatment
quantif
hcv
rna
pcr
brancheddna
assay
method
necessari
monitor
rapid
earli
virolog
respons
antivir
therapi
qualit
quantit
hcv
rna
detect
use
determin
endoftherapi
sustain
virolog
respons
therapi
recombin
immunoblot
assay
riba
similar
sensit
higher
specif
screen
test
formerli
use
confirmatori
test
patient
posit
screen
antibodi
test
hcv
patient
posit
screen
test
neg
riba
result
consid
hcv
infect
ie
fals
reactiv
screen
test
posit
riba
result
two
band
present
indic
chronic
resolv
hcv
infect
wherea
singl
band
detect
consid
indetermin
hepat
c
viru
genotyp
use
guid
choic
durat
antivir
therapi
predict
likelihood
respons
therapi
differ
genotyp
vari
suscept
current
treatment
regimen
human
genom
polymorph
genotyp
cc
within
interferon
gamma
promot
region
associ
increas
likelihood
sustain
viral
respons
individu
chronic
hepat
c
viru
infect
undergo
treatment
pegyl
interferon
ribavirin
strong
predict
valu
spontan
resolut
infect
center
diseas
control
prevent
recent
recommend
adult
born
receiv
onetim
test
hepat
c
viru
enterovirus
often
caus
mening
includ
certain
echoviru
coxsackieviru
serotyp
enterovirus
naat
csf
sensit
cultur
diagnosi
enterovir
central
nervou
system
infect
tabl
plasma
serum
use
diagnosi
sepsi
syndrom
newborn
due
enteroviru
test
less
reliabl
outsid
newborn
period
right
clinic
scenario
recoveri
enteroviru
throat
stool
may
provid
circumstanti
etiolog
evid
central
nervou
system
infect
serolog
evalu
involv
assess
acut
convalesc
titer
typic
use
realtim
clinic
practic
parechovirus
clinic
present
similar
enterovirus
classifi
differ
genu
requir
specif
naat
laboratori
valid
fdaclear
test
detect
commerci
fdaclear
product
avail
rapid
pcr
test
enterovirus
csf
respiratori
syncyti
viru
caus
bronchiol
andor
pneumonia
common
infant
young
children
although
present
older
individu
caus
sever
diseas
immunocompromis
ideal
detect
naat
test
secret
obtain
wash
suction
swab
nasopharynx
tabl
sever
fdaclear
naat
platform
exist
cultur
timeconsum
less
sensit
presenc
igg
gener
indic
past
exposur
immun
presenc
igm
class
antibodi
greater
rise
igg
titer
acut
convalesc
sera
suggest
recent
infect
rapid
diagnosi
influenza
viru
infect
hour
follow
onset
symptom
need
facilit
earli
administr
antivir
therapi
viru
may
rapidli
detect
naat
direct
antigen
detect
nasopharyng
swab
tabl
sensit
higher
naat
rapid
antigen
detect
rapid
screen
test
may
perform
poorli
influenza
season
especi
detect
pandem
swineassoci
strain
neg
test
may
need
confirm
naat
cultur
season
low
preval
influenza
fals
posit
test
like
occur
rapid
screen
procedur
perform
influenza
assay
vari
depend
assay
circul
strain
naat
consid
gold
standard
detect
influenza
viru
clinic
sampl
sever
fdaclear
naat
platform
exist
serolog
evalu
involv
assess
acut
convalesc
titer
typic
use
realtim
clinic
practic
west
nile
viru
eastern
equin
western
equin
saint
loui
california
enceph
virus
caus
central
nervou
system
infect
laboratori
diagnosi
west
nile
viru
typic
accomplish
detect
virusspecif
igm
antibodi
serum
tabl
west
nile
viru
igm
antibodi
may
persist
serum
month
fals
posit
result
may
occur
follow
recent
yellow
fever
immun
natur
infect
flavivirus
eg
dengu
saint
loui
enceph
acut
day
symptom
onset
convalesc
week
later
serum
igg
serolog
may
also
help
posit
antibodi
titer
west
nile
viru
commonli
present
older
individu
especi
indian
subcontin
presum
expos
flavivirus
lifetim
therefor
patient
pretest
probabl
infect
west
nile
viru
low
presenc
west
nile
viru
antibodi
plasma
serum
interpret
cautious
serolog
diagnosi
west
nile
viru
central
nervou
system
infect
base
assess
csf
serum
antibodi
index
detect
west
nile
viru
igm
cerebrospin
fluid
howev
detect
antibodi
cerebrospin
fluid
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
west
nile
viru
naat
insensit
immunocompet
host
sensit
immunocompromis
host
viremia
typic
drop
level
may
undetect
naat
time
symptom
onset
west
nile
viru
naat
test
insensit
central
nervou
system
diseas
viral
cultur
may
avail
special
laboratori
also
insensit
eastern
western
equin
saint
loui
california
enceph
viru
infect
may
diagnos
serolog
follow
strategi
use
west
nile
viru
otherwis
healthi
individu
adenovirus
usual
caus
mild
selflimit
respiratori
ill
case
diagnos
clinic
ground
alon
occasion
adenoviru
infect
immunocompet
host
deadli
especi
children
asthma
immunocompromis
patient
adenovirus
may
caus
pneumonia
dissemin
infect
gastroenter
hemorrhag
cystiti
meningoenceph
hepat
etc
diagnosi
base
naat
cultur
andor
compat
histopatholog
tabl
viral
cultur
long
turnaround
time
reduc
use
shell
vial
technolog
plasma
viral
load
assess
quantit
naat
may
use
marker
preemptiv
therapi
diagnos
adenovirusassoci
sign
symptom
monitor
respons
antivir
therapi
immunocompromis
popul
serolog
test
reli
demonstr
antibodi
groupspecif
antigen
often
requir
analysi
acut
convalesc
sera
serolog
diagnosi
central
nervou
system
infect
base
csf
serum
antibodi
index
fourfold
rise
acut
convalesc
igg
titer
singl
posit
igm
detect
antibodi
csf
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
rabi
viru
infect
central
nervou
system
often
transmit
bite
rabid
anim
state
health
depart
consult
immedi
case
suspect
rabi
singl
test
suffici
diagnos
rabi
antemortem
tabl
test
perform
sampl
saliva
serum
spinal
fluid
skin
biopsi
hair
follicl
nape
neck
saliva
csf
may
test
cultur
naat
laboratoryvalid
serum
csf
may
test
antibodi
rabi
viru
skin
biopsi
specimen
may
examin
rabi
antigen
cutan
nerv
base
hair
follicl
histopatholog
evalu
direct
fluoresc
antibodi
test
brain
biopsi
materi
help
avail
serolog
test
may
use
document
postvaccin
seroconvers
immunocompromis
signific
deviat
prophylaxi
schedul
individu
initi
treatment
intern
noncel
cultur
vaccin
lymphocyt
choriomening
viru
rodentborn
viru
caus
meningoenceph
may
lifethreaten
immunosuppress
person
serolog
diagnosi
base
fourfold
rise
acut
convalesc
igg
titer
singl
posit
igm
tabl
detect
antibodi
csf
may
indic
central
nervou
system
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
csf
serum
antibodi
index
may
help
interpret
csf
antibodi
result
babesiosi
caus
primarili
babesia
microti
us
b
divergen
europ
recent
small
number
infect
occur
california
washington
attribut
b
duncani
unnam
speci
strain
detect
fatal
case
missouri
malaria
caus
plasmodium
falciparum
p
vivax
p
oval
p
malaria
p
knowlesi
latter
primarili
simian
parasit
southeast
asia
recent
recogn
increas
number
human
patient
tabl
summar
laboratori
test
avail
agent
standard
method
diagnosi
parasit
microscop
examin
giemsa
stain
thick
thin
blood
film
although
method
requir
minimum
amount
resourc
stain
materi
high
qualiti
microscop
well
train
experienc
technologist
must
avail
obtain
maximum
accuraci
effici
babesiosi
malaria
seriou
infect
progress
fatal
outcom
diagnos
treat
accur
necessari
health
care
facil
readi
access
rapid
accur
laboratori
test
ideal
sampl
obtain
fresh
capillari
venou
blood
slide
prepar
immedi
howev
typic
practic
obtain
edta
prefer
heparin
anticoagul
blood
transport
sampl
laboratori
slide
prepar
thick
blood
film
essenti
lyse
concentr
allow
rapid
detect
presenc
parasit
consist
either
plasmodium
babesia
gener
allow
definit
identif
thick
film
made
use
drop
blood
lake
lyse
placement
hypoton
stain
solut
releas
intracellular
parasit
allow
examin
multipl
layer
blood
simultan
reason
sensit
method
microscop
screen
allow
detect
low
level
parasitemia
less
rbc
infect
contrast
thin
film
prepar
like
hematolog
peripher
smear
fix
ethanol
stain
fixat
retain
structur
rbc
intraerythrocyt
parasit
provid
ideal
morpholog
plasmodium
speciat
also
allow
optim
evalu
differenti
malaria
babesia
parasit
although
differ
babesia
speci
distinguish
one
anoth
morpholog
alon
stain
best
perform
giemsa
ph
highlight
microscop
featur
parasit
wrightgiemsa
rapid
field
stain
also
accept
thick
thin
film
screen
manual
sinc
autom
hematolog
analyz
may
fail
detect
plasmodium
babesia
speci
parasit
slide
first
screen
low
power
time
final
magnif
identif
larger
microfilaria
follow
examin
oil
immers
laboratorian
examin
minimum
microscop
field
time
total
magnif
thick
thin
film
report
specimen
neg
import
rememb
babesia
plasmodium
may
time
indistinguish
blood
film
transmit
transfus
occur
atyp
clinic
set
clinic
epidemiolog
inform
must
consid
addit
test
may
requir
parasit
identifi
laboratori
expertis
speci
identif
preliminari
diagnosi
plasmodium
babesia
parasit
made
follow
confirmatori
test
refer
lab
situat
primari
laboratori
relay
messag
clinic
team
deadli
parasit
p
falciparum
exclud
consider
repeat
blood
sampl
specimen
drawn
febril
episod
indic
initi
film
neg
malaria
babesiosi
strongli
suspect
plasmodium
speci
identifi
one
enumer
number
infect
rbc
divid
total
number
rbc
count
arriv
percent
parasitemia
best
determin
use
thin
film
quantif
also
perform
use
thick
film
method
less
precis
quantif
may
use
guid
initi
treatment
decis
follow
patient
progress
treatment
altern
giemsastain
blood
film
morpholog
examin
quantit
buffi
coat
qbc
method
test
detect
fluoresc
stain
parasit
within
rbc
requir
special
equip
acquir
maximum
effici
laboratori
multipl
specimen
process
time
seldom
case
u
laboratori
addit
requir
prepar
thin
blood
smear
qbc
sampl
posit
sinc
specif
identif
rate
parasitemia
still
need
determin
latter
method
reason
qbc
method
seldom
use
us
time
although
morpholog
examin
convent
method
diagnosi
malaria
requir
consider
time
expertis
rapid
antigen
detect
test
rdt
malaria
provid
cost
effect
rapid
altern
use
screen
qualifi
technologist
avail
binaxnow
rapid
diagnost
test
recent
approv
fda
rapid
immunochromatograph
card
dipstick
assay
requir
special
equip
special
train
qualifi
technologist
rdt
use
monoclon
antibodi
detect
antigen
p
falciparum
aldolas
common
speci
plasmodium
posit
rdt
confirm
examin
thick
thin
blood
film
also
necessari
determin
speci
p
falciparum
assay
aldolas
posit
neg
present
determin
rate
parasitemia
rdt
somewhat
less
sensit
thick
blood
film
may
fals
neg
case
low
rate
parasitemia
howev
sensit
compar
blood
smear
symptomat
malaria
patient
p
falciparum
infect
addit
rdt
may
fals
posit
sever
day
erad
intact
parasit
sinc
antigen
may
still
detect
therefor
assay
use
follow
patient
adequ
therapi
given
rdt
view
replac
blood
film
rather
substitut
situat
reliabl
blood
film
readili
avail
hour
laboratori
skill
personnel
avail
clinic
situat
critic
immedi
diagnosi
requir
stat
laboratori
emerg
depart
rdt
test
follow
soon
possibl
good
qualiti
thick
thin
blood
film
serolog
play
littl
role
diagnosi
acut
babesiosi
malaria
sinc
antibodi
may
appear
earli
infect
titer
may
low
determin
statu
infect
primari
use
antibodi
detect
epidemiolog
studi
evid
previou
relaps
infect
indirect
immunofluoresc
antibodi
ifa
readili
avail
commerci
assay
babesia
focu
diagnost
cypress
ca
refer
laboratori
igm
titer
igg
titer
indic
acut
infect
rise
titer
igg
titer
neg
igm
titer
rise
serial
specimen
suggest
previou
infect
exposur
insuffici
evid
use
diagnosi
b
divergen
b
duncani
infect
serolog
plasmodium
spp
avail
cdc
rapid
naat
assay
recent
develop
malaria
babesiosi
avail
commerci
refer
laboratori
cdc
although
none
fdaclear
method
compar
sensit
thick
blood
film
requir
special
parasitolog
expertis
naat
may
use
accur
diagnosi
acut
infect
blood
film
neg
difficult
obtain
differenti
malaria
parasit
babesia
nonparasit
artifact
final
naat
may
provid
diagnost
confirm
case
empir
treat
without
prior
laboratori
diagnosi
detect
remnant
nucleic
acid
residu
dna
detect
day
even
week
month
asplen
person
intact
parasit
erad
naat
use
monitor
respons
therapi
naat
posit
plasmodium
babesia
parasit
thin
blood
film
must
still
examin
determin
percent
parasitemia
import
stress
request
malaria
babesiosi
diagnosi
consid
stat
test
perform
rapidli
possibl
naat
assay
may
rapid
limit
refer
laboratori
set
total
turnaround
time
long
enabl
rapid
institut
antimalari
therapi
case
primari
use
naat
confirm
infect
assist
speci
identif
differenti
malaria
babesia
american
trypanosomiasi
may
consist
acut
latent
chronic
phase
optim
diagnost
method
differ
stage
standard
method
diagnosi
american
trypanosomiasi
acut
phase
infect
week
length
microscopi
giemsa
stain
thick
thin
blood
buffi
coat
film
sinc
extracellular
trypanosom
present
time
tabl
blood
film
malaria
babesia
minimum
amount
resourc
stain
materi
high
qualiti
microscop
well
profici
experienc
technologist
must
avail
obtain
maximum
accuraci
effici
stain
prepar
motil
trypomastigot
form
typic
adopt
c
shape
differenti
similar
appear
trypomastigot
brucei
presenc
cruzi
larg
posterior
kinetoplast
comparison
kinetoplast
brucei
trypomastigot
much
smaller
cours
infect
also
like
differenti
epidemiolog
ground
motil
organ
also
observ
fresh
wet
prepar
anticoagul
blood
buffi
coat
although
us
lab
unfamiliar
method
unfortun
infect
rare
diagnos
acut
stage
sinc
infect
individu
present
symptom
time
period
microscopi
less
use
latent
chronic
stage
infect
rate
parasitemia
low
diagnosi
stage
may
establish
serolog
microscop
examin
tissu
aspir
biopsi
nonmotil
amastigot
intracellular
form
cruzi
predomin
phase
infect
cultur
easili
prepar
novymacnealnicol
medium
nnn
similar
media
appropri
blood
tissu
specimen
acut
chronic
stage
add
sensit
laboratori
diagnosi
laboratori
contact
assur
avail
special
media
must
emphas
live
trypanosom
highli
infecti
specimen
must
handl
care
use
standard
precaut
handl
blood
bodi
fluid
serolog
commerci
avail
enzymelink
immunoassay
elisa
kit
greatest
use
latent
chronic
stage
diseas
parasit
longer
easili
detect
peripher
blood
prepar
microscopi
posit
elisa
result
consid
evid
activ
infect
would
exclud
potenti
bloodtissu
donor
test
posit
act
donor
sinc
infect
shown
transmit
transfus
transplant
somewhat
unusu
situat
develop
serolog
test
american
trypanosomiasi
fda
approv
two
commerci
assay
blood
organ
donor
screen
differ
commerci
assay
patient
diagnost
test
assay
use
nonapprov
purpos
even
though
suppos
detect
antibodi
elisa
orthoclin
diagnost
raritan
nj
autom
method
abbott
prism
chaga
abbott
park
il
approv
blood
organ
cell
tissu
donor
screen
wherea
differ
elisa
test
hemagen
diagnost
columbia
md
approv
diagnost
test
donor
screen
test
posit
may
test
fda
approv
supplement
test
abbott
esa
chaga
andor
submit
refer
laboratori
confirmatori
test
radioimmunoprecipit
assay
ripa
hemagen
assay
measur
igg
requir
confirmatori
test
elisa
provid
qualit
posit
neg
result
without
inform
regard
antibodi
titer
